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ABSTRACT 
In South Africa, English-language versions of neuropathic pain screening tools 
typically are used to screen for and diagnose neuropathic pain in the clinical and 
research setting. It is assumed that most individuals understand the English-
language symptom descriptors in these tools (e.g. burning, pins-and-needles, 
aching, tingling or itching) despite English being the first-language of less than 
10% of South Africans. The objectives of this study was firstly to determine what 
isiZulu terms are used to describe the symptoms of neuropathic pain by 
individuals whose home-language is isiZulu, and secondly, to determine the level 
of understanding of typical English neuropathic pain descriptors by these isiZulu 
speakers. Fifty-four participants with symptomatic HIV-associated sensory 
neuropathy (HIV-SN) were recruited to participate in the study. Participants were 
firstly asked to describe, in isiZulu, the pain and/or abnormal sensations in their 
feet and lower legs. Thereafter, a list of common English neuropathic pain 
descriptors was read to participants and they were asked to identify which words 
and phrases described their sensory symptoms. If they identified a particular term 
as describing their symptoms, participants were asked to provide an isiZulu 
equivalent for that English term. Participants typically used the isiZulu words 
“ziyashisa” (hot-48%), “amajaqamba/amacramps” (cramping-35%), 
“ziyaluma/kuyaluma” (itching-22%), “ndikindiki” (numb-22%) or phrases indicating 
numbness in their feet and lower legs to spontaneously describe their symptoms. 
When prompted with English neuropathic pain descriptors, “cramping” (89%) was 
the most selected term followed by the terms “hot” (87%), “burning” (65%), “tight” 
(61%) and “itching” (59%). The English terms that were the least understood by 
participants included “throbbing” (96% of participants did not understand the 
term), “radiating” (83% did not understand the term), “tingling” (78% did not 
iv 
 
understand the term), “pricking” (72% did not understand the term), “aching” 
(70% did not understand the term) and “numb” (63% did not understand the 
term). Overall, when isiZulu speakers with HIV-SN describe their neuropathic 
symptoms spontaneously, the descriptors used are similar to commonly-used 
English neuropathic pain descriptors (when prompted with the terms). However, 
the understanding of English terms can be poor, indicating the need for the 
development of neuropathic screening and assessment tools in languages more 
accessible for the patients who are being assessed. The results obtained 
contribute to a better understanding of the description of neuropathic pain in 
isiZulu speakers, which will aid in the diagnosis and management of neuropathy 
in individuals prone to neuropathy.  
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CHAPTER 1 
LITERATURE REVIEW * 
 
 
 
 
 
 
*A search strategy was performed using the PubMed, Scopus and Science Direct databases. 
Articles and reviews were sourced using the terms “neuropathic pain, neuropathic pain symptoms, 
pain scales, neuropathic pain screening tools and assessment questionnaires, neuropathic pain 
descriptors and HIV-neuropathic pain.” Relevant articles were those that focussed on the 
symptomatology of neuropathic pain and the development and reliability of existing neuropathic 
pain questionnaires. The reference lists of these papers were used to obtain related and relevant 
research articles and review papers. 
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1.1 INTRODUCTION 
Neuropathic pain results when there is damage to the nervous system and is 
common in patients with cancer, diabetes and in individuals infected with the 
Human Immunodeficiency Virus (HIV) (Dworkin, 2002). The symptoms of 
neuropathic pain typically are described as “burning, stabbing, shooting, electric 
shock-like pain, tingling, pins-and-needles and numbness” (Jensen et al., 2001; 
Dworkin, 2002). These characteristic symptoms of neuropathic pain, together 
with a clinical examination form the mainstay of a neuropathy diagnosis (Bennett 
et al., 2007; Cruccu et al., 2010).  
 
Most of the symptom assessments used to diagnose neuropathy were developed 
in English, French or German (Bennett et al., 2007) and then translated into other 
languages such as Turkish, English, Spanish, Italian and Portuguese (Yucel et 
al., 2004; Bouhassira et al., 2005; Perez et al., 2007; Padua et al., 2009; Santos 
et al., 2010). In South Africa, English neuropathic pain questionnaires are 
commonly used to assist the assessment and diagnoses of painful neuropathies 
in the clinical and research settings; however, this may pose a problem as the 
majority of the population does not speak English as a first-language (Census, 
2001). The objectives of this dissertation were to determine the symptomatology 
of neuropathic pain in isiZulu-speaking patients with painful HIV-associated 
sensory neuropathy (HIV-SN), and to determine if English terms commonly used 
in English-language neuropathic pain questionnaires, are understood by isiZulu 
speakers who do not speak English as a first-language. 
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In this chapter, the background for understanding the basis of the study is 
presented, by reviewing pain assessment with a focus on the symptoms of 
neuropathic pain, and the impact culture and language may have on the 
assessment of pain.  
 
1.2 MEASURING PAIN  
Despite the anatomical structures involved in nociception being similar in all 
individuals, pain is a subjective experience and each individual experiences pain 
differently. The manner in which an individual expresses his or her pain is also a 
subjective phenomenon. Many factors including gender, ethnicity, race and age 
may influence how a person perceives, experiences and expresses pain (Zatzick 
and Dimsdale, 1990; Nayak et al., 2000; Sheffield et al., 2000).  
 
Ehlich (1985) suggested three ways in which the pain experience may be 
expressed: i) crying or groaning, ii) pain interjections (e.g. saying “ow” or “ouch”) 
and iii) pain descriptions. Pain interjections and pain descriptions contribute to the 
language of pain: a language that allows communication between two individuals 
to take place so that the pain-free individual may sympathise with the sufferer, 
and possibly assert action to help the sufferer. For example, in the doctor’s 
consulting room, a patient presents the doctor with a series of symptoms and the 
doctor then, using the information, identifies the problem and treats the patient 
(Ehlich, 1985). This expression of pain by the patient leads to the measurement 
of pain by a health care provider and it is important that the verbal expression of 
pain be accurately understood to enhance diagnosis and treatment.  
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However, in countries rich in cultural and language diversity, the “accuracy” of 
pain assessment may become a problem because differences in cultural norms 
for expressing pain and linguistic barriers may lead to poor communication 
between patients and health care providers (Ferguson and Candib, 2002; Hsieh 
et al., 2011). 
 
1.2.1 Cultural and racial differences to pain expression and the role of language 
and culture in the clinical setting 
Culture, race and ethnicity play a role in how an individual perceives, defines, and 
describes pain (Streltzer and Wade, 1981; Zatzick and Dimsdale, 1990; Lasch, 
2000; Nayak et al., 2000; Edwards et al., 2001; Free, 2002). The literature 
describing these cultural and ethnic differences in pain perception and 
expression is extensive, thus in the remainder of this section, illustrative 
examples of these differences will be provided. 
 
Streltzer and Wade (1981) looked at the treatment of pain following 
cholecystectomy surgery in patients from different ethnic groups (Caucasian, 
Hawaiian, Filipino, Japanese and Chinese) living in Honolulu. They found that 
Caucasian and Hawaiian patients required more analgesics to manage their 
postoperative pain as compared to patients with Chinese, Japanese and Filipino 
ethnicity (Streltzer and Wade, 1981). The results suggest differences in pain 
perception, pain tolerance and pain management across cultural groups.   
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Nayak and colleagues (2000) investigated cultural differences between university 
students in India and the United States of America, and found that despite the 
pain intensity of a cold pressor pain being rated similarly in both groups, pain 
tolerance, the ability to endure the pain, was higher for the Indian students. They 
also found that the two groups differed in their beliefs about pain expression. 
Indian students thought that it was less acceptable to show their pain on the 
outside or to make their pain known to others, whereas students from the United 
States approved of openly expressing their pain (Nayak et al., 2000). The authors 
suggested that Americans openly express pain in order to eliminate pain quickly 
and efficiently. Gender differences were also found in the study by Nayak and 
colleagues (2000), with males having higher pain tolerances than females in both 
groups, but Indian men had higher pain tolerances than did American men. 
Importantly, the authors cautioned that health care providers may interpret a 
patient’s pain perception and experience based on their own cultural beliefs 
concerning pain expression, and not that of their patients, which may result in 
inefficient and ineffective pain management (Nayak et al., 2000). As health care 
providers have to rely on the patient’s own verbal explanation and expression of 
pain, it is important that the linguistic, and in some cases cultural, barriers 
between patient and health care providers be resolved.   
 
Nayak and colleagues (2000) only included the students in their study if they 
received at least 10 years of formal English education. In India, English is not the 
home-language for the majority of the population and to exclude those with less 
than 10 years English education may have been a limitation to their study in 
terms of cultural beliefs and pain perception. In South Africa, the majority of the 
population does not receive 12 years of education, let alone 10 years of formal 
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English education. According to the results of the 2001 census in South Africa, 
approximately 17.9% of the adult population received no education, 16% 
received some primary education, 6.4% completed primary school and 
approximately 30% of South African adults received some secondary education 
(Census, 2001). Health care professionals receive at least 15 to 18 years of 
formal education, depending on their profession, whereas most patients receive 
less than 12 years of education, thus creating vast differences in language skills 
in general.  
 
Furthermore, there is great language diversity in South Africa and in sub-Saharan 
Africa. South Africa has 11 official languages: isiZulu, isiXhosa, Afrikaans, 
Sesotho sa Leboa, English, Setswana, Sesotho, Xitsonga, SiSwati, Tshivenda 
and isiNdebele, and according to the census in 2001, 23.82% of the South 
African population speak isiZulu as a home-language (Census, 2001). 
Approximately 17.6% speak isiXhosa as a home-language and less than 10% 
(8.2%) speak English as a home-language (Census, 2001). Other sub-Saharan 
languages include, Shona (Zimbabwe and Southeast Africa), Chichewa 
(Southeast Africa), and, Luhya and Tswana (Southern Africa). It is important to 
note the languages spoken in sub-Saharan Africa, as many people from these 
regions migrate to South Africa. With such a diverse range of languages spoken 
in South Africa by native South Africans and immigrants from sub-Saharan Africa, 
language barriers between health care providers and patients are inevitable, 
possibly resulting in a worsening of health care problems and inadequate pain 
treatment.    
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Ferguson and Candib (2002) conducted a literature review entitled “Culture, 
language, and the doctor patient relationship” and concluded that the relationship 
between the patient and physician were affected by race, ethnicity (culture) and 
language barriers.  For example, patients who were not first-language English 
speakers were unlikely to prompt compassion from their doctors and were also 
unlikely to speak about their pain and thus create a bond with their doctors 
(Ferguson and Candib, 2002).  As these patients did not speak about their pain 
to their doctors, the doctors were less likely to gain the necessary information 
regarding their patients’ condition and the patients’ were also not included in the 
medical decision-making or treatment process. In addition, patients who are not 
fluent in the language of the health care professional may not fully understand 
the value of their pain condition and may not understand the treatment prescribed 
to them, resulting in poor compliance or more visits to the physician to treat the 
pain (Ferguson and Candib, 2002). Adequate communication between doctor 
and patient requires the patient to spontaneously talk about their symptoms or 
the patient to respond to the doctor’s questions on symptoms. The doctor then 
uses the terms used by the patient to describe their condition to determine a 
differential diagnosis of the condition.  
 
South Africa is rich in cultural diversity and it is important to inform those patients 
whose cultural teachings or language barriers with physicians, prevent them from 
seeking medical advice and help about the treatment strategies and options 
available to them. It is equally important for health care providers to make an 
early and correct diagnosis, based on verbal communication, of a possible pain 
condition. Early and correct diagnosis will lead to the initiation of correct 
treatment strategies and can only be achieved by effective communication 
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between patient and health care provider. In addition, effective communication 
will increase the patient’s trust of the health care provider’s decision regarding 
medical treatment and care. 
 
Due to the subjective experience of pain and the differences in culture and 
education levels amongst different individuals, the need for screening and 
assessment questionnaires for pain conditions in languages other than English is 
required to cross these boundaries. 
 
1.2.2 Pain scales 
Although there are different ways to assess pain, measuring pain is problematic 
due to the personal value of the pain experience. In general, there are two main 
types of pain measurements: uni-dimensional scales and multidimensional scales 
(Gracely, 1990). Uni-dimensional scales are simple measures of pain intensity 
and may be either numerical, (e.g. the Numerical Rating Scale where patients 
rate pain on a scale from 0 to 10, 0 being no pain and 10 being severe pain), 
verbal (e.g. the Verbal Descriptor Scale  where patients choose one word to 
describe their pain intensity: mild, moderate or severe pain), or visual, (e.g. the 
visual analogue scale (VAS) where patients rate pain intensity on a horizontal  
line, with no markings, anchored at “no pain” and “worst pain imaginable”) 
(McGuire, 1984; Jensen et al., 1986; Gracely, 1990). Uni-dimensional scales are 
appropriate for use in the clinical setting as sick patients may appreciate the ease 
of use and promptness of such scales when rating their pain intensity, and for 
patients who are poorly educated, these scales are easy to comprehend 
(Chapman et al., 1985). However, although these scales are simple, economical 
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and do not take much time to complete (usually less than 5-10 minutes, including 
explanation, administration and scoring of the scale), they only focus on pain 
intensity, thus simplifying the pain experience into one dimension. Uni-
dimensional scales do not provide a total assessment of the pain experience, 
including the emotional, cognitive and sensory aspects of the pain experience 
which are important for assessing the nature of the pain and the impact the pain 
is having (McGuire, 1984; Chapman et al., 1985).  
 
Multidimensional scales take into account the different qualities and dimensions 
of pain experience, for example, the sensory, spatial, emotive and affective 
dimensions of pain, as well as the location of pain, pain intensity and pain 
evaluation (McGuire, 1984; Gracely, 1990). Multidimensional scales may lead to 
better psychophysical, psychosocial and psychological assessments of pain than 
uni-dimensional scales, but they are usually time-consuming (taking 
approximately 15-30 minutes to explain to patients and to administer, and a 
further 10 minutes to score) and they are challenging to analyse (McGuire, 1984; 
Gracely, 1990). Furthermore, patients or subjects may find difficulty in 
understanding some of the terms used in these scales (Chapman et al., 1985). 
 
Nociceptive pain is pain generated from stimulation of the primary afferents, is 
either somatic or visceral and is linked to inflammation, whereas neuropathic pain 
occurs when there is damage or trauma to the nervous system and can be 
peripheral or central in origin (Woolf and Mannion, 1999; Jensen et al., 2001; 
Dworkin, 2002; Urgellés-Lorié, 2008). As neuropathic pain is different from 
nociceptive pain in origin, one would expect differences in the sensations 
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experienced and therefore, the verbal description used to express neuropathic 
and nociceptive pain would also be different. There are no questionnaires 
specifically designed to diagnose nociceptive pain, but the unique symptom 
clusters that typically accompany neuropathic pain, irrespective of its possible 
cause, has led to several assessment and diagnostic tools being developed for 
neuropathic pain (Bennett et al., 2007; Cruccu et al., 2010).    
 
The use of verbal pain descriptors has been shown to be effective when 
assessing the sensory and affective qualities of neuropathic pain and may also 
be used diagnostically in some pain conditions (Dubuisson and Melzack, 1976; 
Boureau et al., 1990). We will first discuss the development and validation of a 
pain questionnaire that was not designed for diagnosis of a specific pain 
condition, but for the assessment of pain in general: the McGill Pain 
Questionnaire. We will then focus on neuropathic pain and the questionnaires 
that were specifically designed to screen for and assess neuropathic pain 
conditions, their development and how they may differ from one another. We will 
focus mostly on the symptom component of the questionnaires. 
 
1.2.3 The development of the McGill Pain Questionnaire (MPQ) 
The McGill Pain Questionnaire (MPQ) originated from a wordlist created by 
Ronald Melzack and Warren Torgerson in 1971, and was the first 
multidimensional questionnaire to assess the quality of spontaneous pain 
(Melzack and Torgerson, 1971; Melzack, 1975). The need for a questionnaire 
such as the MPQ arose as, during that time, most of the tools used for pain 
measurement focussed on pain intensity only and failed to take into account the 
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“unique qualities” of different types of pain (Melzack, 1975).  Accordingly, in 1971, 
Melzack and Torgerson created a wordlist focussing on multiple dimensions of 
the pain, to assist with the assessment and description of pain in humans 
(Melzack and Torgerson, 1971). The 102 terms on the list were sourced from the 
literature on clinical pain. The terms covered 3 classes of pain quality: sensory, 
affective and evaluative, and 13 subclasses for the sensory and affective classes: 
temporal, spatial, punctate pressure, incisive pressure, constrictive pressure, 
traction pressure, thermal, brightness, dullness, tension, autonomic, fear and 
punishment. 
 
The wordlist was given to 20 subjects who were asked to identify if the 
descriptive words were placed in the correct subclass (Melzack and Torgerson, 
1971). Eleven words, including “itching, tearing, taut, awful” and “wicked,” 
showed less than 65% concordance as belonging to a specific subclass and 
were then given to 20 different subjects who were asked to place these words in 
the appropriate subclass. Thereafter, all 102 words were presented to 140 
university students, 20 doctors and 20 patients, who were asked to relate each 
word with a pain intensity rated on a numerical pain rating scale. All 3 groups of 
subjects showed strong agreement on the position of the words in each group. 
For example, in the thermal group, hot was associated with less pain than 
burning which was associated with less pain than scalding and the words in each 
group are thus placed in order of increasing pain intensity (Melzack and 
Torgerson, 1971). This wordlist, comprising 3 classes and 16 subclasses of pain 
descriptors was then used in the development of the MPQ.   
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In 1975, Melzack added a Present Pain Intensity (PPI) scale to the wordlist 
created by himself and Torgerson (Melzack, 1975).  The PPI consists of five 
words; each associated with a number corresponding to pain intensity: 1=mild 
pain, 2=discomforting pain, 3=distressing pain, 4=horrible pain and 
5=excruciating pain. The wordlist and PPI was then used in a pilot study where 
Melzack realised that certain important descriptors that patients wanted to use to 
describe their pain were not on the wordlist he and Torgerson had developed. He 
then added these missing words from wordlists that he and Torgerson used when 
creating their 102-wordlist. He also added another group of words to the list: cool, 
cold and freezing as these terms described a few pain conditions, even though 
they were not commonly used by patients (Melzack, 1975).  
 
Melzack thus added 4 extra subclasses to the wordlist and the final list consisted 
of 3 classes with 20 subclasses (Melzack, 1975). The final version of this list is 
known as the MPQ and consists of 78 pain descriptors in total. A Pain Rating 
Index (PRI) is calculated once a patient completes the MPQ. For example, if a 
patient chose “hot” to describe the pain, he would get a rank value of 1 in that 
group.  “Searing” would render a rank value of 4. When all the rank values from 
each group selected are added up, the total number represents the PRI. The 
higher the PRI, the greater the pain experience. The PRI has been validated and 
correlates well with the overall number of words chosen (Melzack, 1975).  
 
The ability of the MPQ to differentiate between different types of pain has also 
been studied. Dubuisson and Melzack (1976) sought to determine if the MPQ 
could be used as a diagnostic tool. They recruited 95 patients who had already 
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been clinically diagnosed with differing pain conditions: menstrual pain, 
rheumatoid arthritis, labour pain, degenerative disc disease, toothache, metastic 
carcinoma, phantom limb pain and postherpatic neuralgia (Dubuisson and 
Melzack, 1976). All patients, in an interview format, were asked to choose words 
from the MPQ that accurately described their present pain and to complete the 
PPI. A stepwise multiple group discriminant analysis was used to analyse the 
data and the results showed that 77% of patients were correctly diagnosed based 
on the verbal descriptions they provided to describe their pain (Dubuisson and 
Melzack, 1976). The final version of the MPQ is shown in Appendix 1. While the 
MPQ is an invaluable tool for describing pain quality of a sensory, affective and 
cognitive level, it consists of many obscure English terms and it is lengthy and 
time consuming to complete and due to limited time available in clinical and 
research settings, the need for a shorter form of the MPQ became apparent.  
 
1.2.3.1 The short form MPQ (SF-MPQ)  
Lengthy questionnaires are a problem in the clinical setting as patients may be 
too ill or fatigued to fill out the questionnaire with ease. In the research setting, 
the lengthy version of the MPQ is a problem as time management is important for 
participants and they may be unwilling to spend a considerable amount of time 
filling out the MPQ, particularly if repeated measures are required. In 1987, the 
short form of the MPQ (SF-MPQ) was developed and validated by Melzack as it 
was more time efficient than its parent questionnaire (Melzack, 1987). The SF-
MPQ consists of a VAS and PPI to rate pain intensity and 15 pain descriptors 
from the original MPQ: 11 sensory items and 4 affective items. Patients are 
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required to score each pain descriptor on the short form as 0-no pain, 1-mild 
pain, 2-moderate pain and 3-severe pain (Melzack, 1987).   
 
To generate the items that would appear on the SF-MPQ, Melzack (1987) looked 
at those words that were commonly chosen by at least one third of patients, from 
previous studies, with a range of pain conditions including post-surgical pain, 
labour pain, dental pain, cancer, menstrual pain, arthritis and low back pain. The 
list consisted of 15 items that was validated against the standard MPQ (Melzack, 
1987). The 15 items included in the SF-MPQ are:  
• throbbing 
• shooting 
• stabbing 
• sharp 
• cramping 
• gnawing 
• hot-burning 
• aching 
• heavy 
• tender 
• splitting 
• tiring-exhausting 
• sickening 
• fearful and  
• punishing-cruel 
 
1.2.3.2 Validation of the SF-MPQ (Melzack, 1987) 
For the validation, both the SF-MPQ and the standard MPQ were read to patients 
with post-surgical, obstetrical or musculoskeletal pain before the patients 
received any pharmacological or other therapy and 30 minutes after therapy. The 
forms were administered in the following order: first the standard MPQ and then 
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the short form. Patients were asked to rate the pain intensity of the word or words 
that described their pain on a VAS. In addition, a similar intervention was carried 
out in patients with post surgical or dental pain. The need for the second 
intervention arose as the order in which the forms were given during the first 
intervention may have had an impact on the results. In the second intervention, 
the order of questionnaire administration was randomised. The results obtained 
from both interventions showed that all the descriptors on the short form were 
significantly correlated to those on the long form irrespective of the nature of the 
pain and the sequence in which the forms were given to patients. 
 
Although the standard MPQ could correctly distinguish between the different 
types of pain, as shown by Dubuisson and Melzack in 1976, the most difficult 
pain to describe appears to be that of neuropathic pain. 
 
1.3 NEUROPATHIC PAIN 
Neuropathic pain is caused by damage or trauma to the peripheral or central 
nervous system and does not occur due to continuous tissue injury (Jensen et al., 
2001; Dworkin, 2002).  Examples of peripheral neuropathic pain syndromes 
include chemotherapy-induced neuropathy, painful diabetic neuropathy, phantom 
limb pain, trigeminal neuralgia and HIV-SN, while central neuropathic pain 
syndromes include central post-stroke pain, multiple sclerosis, Parkinson’s 
disease and spinal cord injury pain (Jensen et al., 2001; Dworkin, 2002; 
Bouhassira et al., 2008). Chronic pain with neuropathic characteristics seems to 
be more prevalent in females (Bouhassira et al., 2008), and the risk of developing 
neuropathic pain increases with age (Bouhassira et al., 2008; Robinson-Papp et 
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al., 2010). Due to the vast number of causes of neuropathic pain, the prevalence 
of neuropathic pain in the general population may be relatively high as was found 
in the United Kingdom and in France, but there is shortage of epidemiological 
data concerning neuropathic pain (Torrance et al., 2006; Bouhassira et al., 2008). 
However, despite the various causes associated with neuropathic pain, 
neuropathic pain usually presents with similar symptoms and signs in patients 
(Jensen et al., 2001; Dworkin, 2002; Bouhassira et al., 2008; Robinson-Papp et 
al., 2010).  
 
Pain associated with neuropathy can occur either spontaneously or may be 
caused by a stimulus (stimulus-dependent) (Jensen et al., 2001; Dworkin, 2002). 
Spontaneous pain may be continuous, often described as “aching, burning or 
cramping” (Woolf and Mannion, 1999; Jensen et al., 2001; Krause and Backonja, 
2003), or may occur at intervals, frequently described as “stabbing, shooting or 
electric shock-like” (Bennett, 2001; Krause and Backonja, 2003; Bouhassira et 
al., 2004). Stimulus-dependent pain may be caused by a stimulus that is not 
usually perceived as painful (allodynia), or the patient may experience increased 
pain in response to a stimulus that is usually perceived as painful (hyperalgesia) 
(Woolf and Mannion, 1999; Jensen et al., 2001; Krause and Backonja, 2003; 
Bouhassira et al., 2004; Portenoy, 2006). Patients may also experience 
dysesthesias, abnormal sensations that are unpleasant, such as itching, tingling 
or numbness, as well as paresthesias, abnormal sensations that are not 
unpleasant, such as pins-and-needles (Dworkin, 2002; Krause and Backonja, 
2003; Bouhassira et al., 2004; Bouhassira et al., 2005). 
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As the above-mentioned symptoms are fairly unique to neuropathic pain 
syndromes, a clinical diagnosis of neuropathy is usually made when a patient 
presents with symptoms (similar to what has been described) and signs of a 
neuronal deficit consistent with the anatomical location of the symptoms (Treede 
et al., 2008; Cruccu et al., 2010). Signs indicating a potential neuropathy include 
loss of function, a negative sensory sign that includes numbness, weakness, 
areflexia or hyper-reflexia, and positive sensory signs including hyperalgesia or 
allodynia (Rolke et al., 2002; Treede and Baron, 2008; Cruccu et al., 2010). 
These symptoms and signs are commonly found on assessment and diagnostic 
tools related to neuropathic pain and assist with the evaluation and diagnosis 
thereof. 
 
1.3.1 The diagnostic property of the MPQ for neuropathic pain  
The MPQ has been tested as a diagnostic tool in patients with painful diabetic 
neuropathy (Masson et al., 1989). The descriptions from the MPQ of 42 patients 
with diabetic neuropathy were compared to the pain descriptions from the MPQ 
obtained from 49 patients with non-neuropathic pain in the feet and legs. A linear 
discriminant analysis showed that 79% of neuropathic pain patients and 86% of 
patients with non-neuropathic pain were correctly diagnosed based on 
descriptions from the MPQ (Masson et al., 1989). Similarly, Boureau and 
colleagues (1990) aimed to determine if the use of verbal pain descriptions could 
accurately diagnose neuropathic pain in neuropathic pain patients. One hundred 
patients with various causes of neuropathic pain (97 patients with chronic benign 
pain were in the control group), were assessed in the study and were asked to fill 
out a French reconstruction of the MPQ. The questionnaire consisted of 61 pain 
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descriptors and patients were asked to choose which of these words best 
described their pain (Boureau et al., 1990).   
 
The most frequently chosen words by patients with neuropathic pain were 
“burning, electric shock, tingling, pricking, itching” and “cold” (Boureau et al., 
1990). The term “shooting,” which is also commonly used to describe neuropathic 
pain, did not significantly differ from the non-neuropathic group. All words relating 
to the affective component of pain were not commonly chosen by patients with 
neuropathic pain. Seventeen out of the 61 descriptors were found to reach a 
significant intergroup difference and were included in further factor analysis and 
stepwise analysis. The factor analysis produced a 7-factor solution and the terms 
relating to the different aspects of neuropathic pain were placed in different 
factors, namely, intermittent pain (“electric shock”), permanent pain (“burning”) 
and dysesthesias (“tingling, pricking” and “itching”). The stepwise discriminant 
analysis showed that four terms (“electric shock, itching, tingling” and “burning”) 
could be used to correctly diagnose patients with neuropathic pain (Boureau et 
al., 1990). The authors also state that the therapeutic value associated with the 
correct identification of pain is important as it may encourage patients to 
recognize pain as an indication of an underlying problem and thus patients, by 
definition, are already seeking help. 
 
However, the findings of Rasmussen and co-workers (2004) are in contrast to 
those of Boureau and colleagues (1990). Rasmussen and co-workers found that 
descriptive words could not separate patients with neuropathic and non-
neuropathic pain. The authors used a Danish version of the SF-MPQ in their 
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study and found no differences in the selection of the typical neuropathic pain 
descriptors “burning/scalding, shooting and pricking” between patients with either 
definite or potential neuropathic pain, and patients with pain unlikely to be caused 
by a neuropathy (Rasmussen et al., 2004). The term “burning” differed between 
patients with central neuropathy and peripheral neuropathy, but could not 
distinguish between neuropathic pain patients and those less likely to have 
neuropathic pain. It is unclear whether their results are peculiar to the Danish 
language and culture, or whether they reflect the complexity in trying to diagnose 
neuropathic pain using only symptoms, as is the case when using the MPQ.  
 
The MPQ and SF-MPQ are both non-specific questionnaires for neuropathic pain 
and include a range of pain descriptors that take into account all types of pain 
conditions. Although the items on the MPQ can assist in diagnosing neuropathic 
pain, there are too many items and using the MPQ for diagnosis of neuropathic 
pain may become a tedious task. In addition, no clinical signs of a neurological 
disease are assessed and the affective items on the MPQ are not frequently used 
to describe neuropathic pain as the description of neuropathic pain takes on a 
more sensory dimension (Boureau et al., 1990; Rasmussen et al., 2004). The 
short-comings of the MPQ and SF-MPQ for assessing neuropathic pain created 
demand for specific neuropathic pain assessment and diagnostic tools. These 
tools included pain descriptions common, but not necessarily unique, to 
neuropathic pain, included an assessment of signs where possible, and did not 
consume too much time to administer and score, thus making the new tools 
practical for clinical use. In the next sections, some of the more popular 
neuropathic pain assessment and diagnostic tools will be described.  
20 
 
1.3.2 Neuropathic Pain Scale (NPS) 
The Neuropathic Pain Scale (NPS) is an assessment tool and was developed in 
1997 by Galer and Jensen in the United States of America (Galer and Jensen, 
1997). The NPS was developed specifically to evaluate the different symptoms of 
neuropathic pain as there were no other questionnaires developed for 
neuropathic pain conditions at that time, other than the non-specific MPQ and 
SF-MPQ. The NPS was developed in English and the aim of the development of 
the NPS was to create a pain measure that took into account all the pain qualities 
common in neuropathic pain patients (Galer and Jensen, 1997). The 
questionnaire assessed symptoms only, and not signs, and is therefore useful for 
the characteristics of the sensory aspects of neuropathic pain but not for the 
diagnosis of neuropathic pain when used alone. 
 
1.3.2.1 Development and validation of the NPS (Galer and Jensen, 1997) 
The authors’ used their subjective clinical experience to select the terms used on 
the scale, selecting the most common words used by patients with neuropathy to 
describe their pain. The NPS includes eight items related to the symptoms of 
neuropathic pain, one item related to the intensity of neuropathic pain and one 
item related to how unpleasant the pain is. Patients rate whether they have a 
symptom listed on the scale and they rate the severity of the symptom on an 11-
point pain rating numerical scale. The eight symptom items are: 
• sharp 
• hot 
• dull 
• cold 
• sensitive 
• itchy 
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• deep pain and 
• surface pain 
 
The scale was validated in two separate interventions. The first intervention 
consisted of 288 patients with neuropathic pain of mixed origin (post-hepatic 
neuralgia, reflex sympathetic dystrophy, traumatic peripheral nerve injury and 
painful diabetic neuropathy). Patients were asked to complete the questionnaire 
and rate the intensity of their symptoms. A Pearson’s correlation coefficient 
between all 10 descriptors was used to determine if these terms truly assessed 
the symptoms of neuropathic pain. Thereafter, a chain of 10 Analysis of 
Variances was carried out to determine if the items on the NPS could distinguish 
between the different neuropathy diagnoses. The results showed that the items 
“sharp, cold, sensitive” and “itchy” were able to discriminate post-hepatic 
neuralgia from the other diagnostic groups, but the NPS could not distinguish 
between the remaining three neuropathic pain groups. 
 
The second intervention consisted of 78 patients with neuropathic pain of mixed 
origin (traumatic peripheral nerve injury, reflex sympathetic dystrophy, diabetic 
neuropathy, causalgia and spinal cord injury) who received infusions of lidocaine 
and phentolamine to treat their pain (Galer and Jensen, 1997). The aim of the 
second intervention was to determine the sensitivity of items found on the NPS to 
neuropathic pain treatments. Patients were required to fill out the NPS before and 
after they received the treatments. The authors found that most of the symptoms 
of neuropathic pain on the NPS decreased after lidocaine administration and 
phentolamine infusion. They also found that lidocaine was more successful at 
improving “deep” pain and “unpleasant” sensations than phentolamine. Based on 
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their validation studies, they suggest using the NPS in studies focussing on 
neuropathic pain symptoms and the treatment thereof (Galer and Jensen, 1997). 
 
The results from the two validity interventions proved that the NPS is effective 
when assessing the unique pain qualities associated with neuropathic pain and 
that the majority of the items on the scale are sensitive to the effects of 
neuropathic pain treatment (Galer and Jensen, 1997). However, as there are only 
10 items on the NPS, the NPS does not cover the range of symptoms 
experienced by patients with neuropathic pain (Galer and Jensen, 1997). This 
may have encouraged the development of other neuropathic pain assessments. 
The NPS was also not assessed for use in nociceptive pain, and can therefore 
not distinguish between neuropathic and nociceptive pain.   
 
1.3.3 Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) Pain 
Scale 
The Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) Pain 
Scale is a diagnostic tool that can differentiate between neuropathic and non-
neuropathic pain and was developed and validated in 2001 in two separate 
interventions that are described in the same paper (Bennett, 2001). The LANSS 
was developed as the NPS could not distinguish between neuropathic and non-
neuropathic pain conditions. The first intervention focussed on the construction of 
the pain scale and the second intervention tested the validity and reliability of the 
pain scale (Bennett, 2001).  
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1.3.3.1 Development and validation of the LANSS (Bennett, 2001) 
The initial scale was constructed using pain descriptions that were sourced from 
published data and patient surveys, and consisted of six groups of terms related 
to neuropathic pain symptoms, and each symptom was phrased in a question 
format. The dimensions of pain in the six groups included stimulus-independent 
pain (ongoing superficial pain with thermal qualities, ongoing superficial pain with 
dysesthesias-like qualities, ongoing spontaneous deep pain and paroxysmal 
pain), stimulus-dependant pain and autonomic dysfunction. 
 
In an interview with 60 patients (30 with neuropathic pain; 30 with nociceptive 
pain), the scale was read to patients and they were required to decide in a 
“yes/no” format, which questions described their pain. Patients were also 
exposed to two sensory functioning tests: pin-prick threshold and the presence or 
absence of allodynia. In addition, they were asked to rate their pain intensity over 
the past week and provide information on how frequently the pain had occurred 
in the last week. Logistic regression modelling analysis was used to determine 
which descriptive words and sensory tests could, together, predict whether a 
patient had a neuropathic pain condition. Both groups of patients were equal in 
pain intensity and pain frequency, but there were more patients with neuropathic 
pain who had a raised pin-prick threshold and the presence of allodynia. In 
addition, the question pertaining to ongoing deep pain was selected frequently by 
patients with neuropathic and those with nociceptive pain, and was thus 
eliminated from the construction of the final version of the scale.  
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The final version of the LANSS Pain Scale is divided into two components: a pain 
questionnaire and a sensory testing component (Bennett, 2001). Below are two 
examples of the pain questionnaire component of the LANSS: 
1) Does your pain feel like strange, unpleasant sensations in your skin? Words 
 like pricking, tingling, pins-and-needles might describe these sensations. 
  a) NO-My pain doesn’t really feel like this............................ (0) 
  b) YES-I get these sensations quite a lot.............................. (5) 
5) Does your pain feel as if the skin temperature in the painful area has changed 
abnormally? Words like hot and burning describe these sensations.  
a) NO-I don’t really get these sensations.............................. (0) 
 b) YES-I get these sensations quite a lot............................... (1) 
           [Extracted from the LANSS Pain Scale by Michael Bennett (2001)]. 
 
The LANSS Pain Scale contains seven items in total and the pain questionnaire 
contains five symptom items assessing:  
• pricking, tingling, pins-and-needles 
• electric shocks, jumping or bursting 
• hot or burning 
• pain caused by light touching and  
• autonomic changes 
 
The sensory testing on the scale includes two clinical examination items:  
• brush allodynia and a raised pin-prick threshold. 
  
Each question with the related pain items is given a specific score on the scale. 
The score was obtained by using a scoring system that uses the odds ratio for 
each item on the scale (Bennett, 2001). The odds ratio was calculated for each of 
the following groups: thermal, dysesthesias, paroxysmal, evoked pain, 
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autonomic, allodynia and an altered pin-prick threshold.  For example, the odds 
ratio for the thermal group was 1(1.41), therefore the question pertaining to hot or 
burning pain was given a score of 1 if those symptoms are present in the patient. 
The odds ratio for dysesthesias group was 5(5.24) so if the patient presents with 
pricking, tingling or pins-and-needles, the patient would be given a score of 5. 
The final overall maximum score obtainable using the scoring method was 24 
and, with the value of 12 providing the lower threshold for classifying a patient as 
being more likely to have pain of neuropathic origin than nociceptive pain 
(Bennett, 2001).  
 
The scale was then validated and its reliability was examined in a separate 
intervention consisting of 40 patients with neuropathic or nociceptive pain (20 
patients in each group) (Bennett, 2001). Patients were required to complete the 
scale on two different occasions. On the first occasion, the investigator assisted 
the patient with completing the scale and on the second occasion, a clinician 
assisted the patient with completing the scale. The scores from the investigator 
and clinician were then compared to evaluate the validity and reliability of the 
scale between investigator and clinician.  
 
There were no significant differences between patients with neuropathic pain and 
nociceptive pain in terms of pain intensity and pain frequency. There were also 
no significant differences between the investigator and clinician with regards to 
LANSS scores, pain classification and the items present on the LANSS Pain 
Scale. When compared, the clinician and investigator could correctly identify 33 
out of the 40 patients as having neuropathic pain using the LANSS Pain Scale, 
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using a cut-off score of 12 or more (with a specificity of 80% and a sensitivity of 
85%). The results from the second intervention also showed that each item on 
the scale was positively associated with neuropathic pain and, as no item was 
redundant, no other item was removed. The LANSS is thus a reliable tool for 
differentiating neuropathic pain from non-neuropathic pain and is used as a 
diagnostic tool (Bennett, 2001). 
 
1.3.3.2 Development and validation of the self-completed LANSS (S-LANSS) 
(Bennett et al., 2005) 
In 2005, the self-completed LANSS (S-LANSS) was developed to identify 
neuropathic pain in the clinical setting and in population surveys. S-LANSS was 
developed from the original LANSS questionnaire (Bennett, 2001). The two 
sensory test items were reworded so that the questions ask the patients to 
examine themselves as the S-LANSS is to be self-completed (Bennett et al., 
2005). Other pain items were modified to make the words clearer and the scoring 
system for both, sensory test items and pain descriptions, remained the same as 
the scoring system on the original LANSS. Additional changes on the S-LANSS 
was the inclusion of a body chart and an 11-point numerical pain rating scale 
anchored at “no pain” and “pain as severe as it could be.” As with the original 
LANSS, a total score of 12 out of 24 suggests neuropathic pain (Bennett, 2001; 
Bennett et al., 2005). S-LANSS was validated in two independent studies: a clinic 
validation study and a postal survey validation study and is the only tool to have 
been validated against an existing neuropathic pain measurement, the NPS 
(Bennett et al., 2005). 
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In the clinic validation study, the sample size consisted of 200 patients 
(100=neuropathic pain, 100=nociceptive pain) who were asked to fill out the S-
LANSS without aid from a researcher and, thereafter, in an interview format, a 
researcher read out the S-LANSS and NPS to patients (Bennett et al., 2005). 
This was done so that unaided data could be compared to interview data. In 
addition, clinicians who assisted with diagnosis were asked to rate the certainty of 
the diagnosis of neuropathic pain on a 10cm VAS. This was done to determine if 
the S-LANSS could predict neuropathic pain from non-neuropathic pain.  
 
The results of a discriminant validity analysis showed that the S-LANSS could 
correctly distinguish between the two types of pain in the unaided and interview 
format when compared to the clinical diagnosis.  A convergent validity analysis 
showed that five of the items on the NPS (sharp, hot, cold, sensitive and intensity 
of surface pain) were successful at determining neuropathic pain as these items 
were associated with a clinical diagnosis of neuropathic pain. These same 5 
items were also associated with a score of 12 or more on the S-LANSS and an 
additional 3 items (intensity, itchy and unpleasantness) were also associated with 
a score of 12 or more on the S-LANSS. These results showed that the S-LANSS 
had similar psychometric properties to the NPS, a validated tool.  
 
For the postal validation study, two patient populations were recruited to 
participate (Bennett et al., 2005). The first consisted of 160 patients from a 
general practice population and the second population consisted of 150 patients 
from a pain clinic. All 310 patients were posted the S-LANSS, NPS and a 
demographic questionnaire and 174 patients responded to the survey. The 
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responses from the 174 patients (general practice population and pain clinic) 
were combined for analysis. The five items on the NPS (from the clinical 
validation study) were used as an indicator for possible neuropathic pain as there 
was no clinical diagnosis in the postal survey study. From the 174 patients, 58 
had an S-LANSS score of 12 or more and produced greater combined intensity 
scores on the NPS compared to patients with non-neuropathic pain. In addition, 
patients with neuropathic pain also produced greater scores on the five NPS 
items from the clinic validation study. The S-LANSS is thus validated in postal 
research as a diagnostic tool for neuropathic pain. The S-LANSS is an efficient 
and valid tool that can be used to identify neuropathic pain in clinical settings and 
in postal research. 
 
1.3.4 Neuropathic Pain Questionnaire (NPQ) 
The purpose of the Neuropathic Pain Questionnaire (NPQ), developed by Krause 
and Backonja in 2003, was to provide a universal evaluation of the symptoms 
related to neuropathic pain and to distinguish between pain that is neuropathic in 
nature and pain that is non-neuropathic (Krause and Backonja, 2003). The NPQ 
was developed as the NPS could not distinguish between neuropathic and non-
neuropathic pain and, although the LANSS Pain Scale was developed for this 
very reason, it only focussed on four of the pain descriptor groups. The NPQ was 
developed as an assessment tool as well as a diagnostic tool, but only relies on 
symptoms for the diagnosis, which as already discussed for the MPQ, may be a 
limitation. 
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1.3.4.1 Development and validation of the NPQ (Krause and Backonja, 2003) 
The initial NPQ consisted of 32 items that were obtained from patient charts at 
the University of Wisconsin Hospital and Clinics Pain Clinic and from reviewing 
literature on neuropathic pain. Initially, the study sample consisted of 532 patients 
with various pain aetiologies, but only data from those with neuropathic pain and 
non-neuropathic was used for further analysis. The 32-item questionnaire was 
given to patients from the remaining 382 patients (149 presented with pain of 
neuropathic origin and 233 had non-neuropathic pain) who were willing to answer 
the questionnaire. Patients were required to rate their pain on a numerical scale 
ranging from 0 to 100 for each item they chose.   
 
Factor analysis yielded 6 factors and the 32-item questionnaire was reduced to 
12 items loading on those factors: 10 items related to the sensations or sensory 
responses of neuropathic pain and 2 items related to affect. The 32 items were 
also subjected to t-tests and those items that could distinguish between 
neuropathic and nociceptive pain were further analysed. Those items that were 
significantly different from each other for nociceptive and neuropathic pain at a 
level of p<0.001, were analysed using a multiple discriminant analysis to find out 
the extent to which each term could distinguish between the two pain states. The 
final version of the questionnaire consists of 10 items related to sensations or 
sensory responses of neuropathic pain: 
• burning 
• overly sensitive to touch 
• shooting 
• numbness 
• electric 
• tingling 
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• squeezing 
• freezing 
• unpleasantness and 
• overwhelming 
 
The two items related to affect are: increased pain due to touch or pressure and 
increased pain due to changes in weather. Examples of the items “burning pain” 
and “numbness” are provided below: 
1. Burning pain 
(No burning pain )  0                                                                                                                                   100 
                    (worst burning pain 
               imaginable)  
Please rate your usual pain: _________ 
4. Numbness 
(No numbness)      0                                                                                                                                   100 
                       (worst numbness 
               imaginable)  
Please rate your usual pain: ________ 
[Extracted from the NPQ by Krause and Backonja (2003)]. 
 
A scoring sheet is provided on the NPQ and calculation of the score determines if 
the patient has pain of neuropathic origin or not (Krause and Backonja, 2003). 
For each term on the NPQ, a different coefficient (sourced from the discriminant 
analyses) is provided. In order to determine the final score, the rating provided by 
the patient is multiplied by the coefficient for each term. The product for all 12 
items is then added up together with a constant provided on the NPQ and a 
score below 0 means that the patient has non-neuropathic pain whereas a score 
of 0 or above predicts a neuropathic pain state. 
 
The NPQ is a diagnostic and assessment tool that can distinguish neuropathic 
pain from non-neuropathic pain and the authors also suggest that the NPQ can 
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be used to monitor treatment effects (Krause and Backonja, 2003). However, the 
scoring is complicated and it doesn’t include assessment of signs. Moreover, the 
NPQ cannot distinguish between the different types of neuropathic pain.  A short-
form of the NPQ was developed in an attempt to find out what was the minimum 
number of words that were useful in predicting neuropathic pain conditions 
(Backonja and Krause, 2003). The subjects included in this study were those that 
had participated in the development of the long form of the NPQ. The final 
sample size consisted of 278 subjects with either neuropathic pain (n=110) or 
non-neuropathic pain (n=168) and who had completed the long form of the NPQ. 
A stepwise discriminant analysis was used to analyse the 12 items on the long 
form and the results produced 3 items; numbness, tingling and increased pain in 
response to touch, that could accurately distinguish neuropathic pain from non-
neuropathic pain with a sensitivity of 64.5% and a specificity of 78.6% (Backonja 
and Krause, 2003). 
 
Despite the now growing number of questionnaires validated for neuropathic pain 
conditions, more assessment tools and diagnostic tools were developed. 
 
1.3.5 Neuropathic Pain Symptom Inventory (NPSI)  
The Neuropathic Pain Symptom Inventory (NPSI) was developed by Bouhassira 
and colleagues in 2004 in French to evaluate the different symptoms of 
neuropathic pain with respect to the characteristics and intensity of neuropathic 
pain, and is an assessment tool, not a diagnostic tool, for neuropathic pain 
(Bouhassira et al., 2004).  It was developed for use as a self-administered 
questionnaire, and, as such the questionnaire is practical to use in large cohorts 
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of patients in multicenter studies. The initial version of the NPSI was created 
using terms based on clinical experience and terms extracted from the literature. 
A group consisting of 7 French and Belgium pain experts discussed and 
approved these 18 items that were to be part of the initial NPSI (Bouhassira et 
al., 2004).  
 
1.3.5.1 Development and validation of the NPSI (Bouhassira et al., 2004) 
 The use of the 18 items was validated in a pilot study consisting of 39 patients 
with neuropathic pain. Participants were asked to complete the initial 18-term 
questionnaire and for each item, participants had to report the clarity of the 
wording, understanding and significance of each term with respect to their pain 
symptoms. This questionnaire consisted of four dimensions relative to 
neuropathic pain, namely, spontaneous ongoing pain (six items), spontaneous 
paroxysmal pain (four items), evoked pain (four items) and items related to 
paresthesias or dysesthesias (four items). After analysis of the data obtained in 
the pilot study, the word “dull” was removed as majority of the participants 
considered the term to be unrelated to their neuropathic pain.  
 
The 17-item scale was then presented to 176 patients, with either peripheral or 
central nerve damage, to test the validity of the final version of the NPSI. The 
scale was then reduced to 12 items after factor analysis was performed and 
Intraclass Correlation Coefficient (ICC) was determined. The factor analysis 
yielded a 5-factor solution.  “Numbness, painful cold, cramp, lancinating” and 
“itching” were removed as they showed poor reliability with the ICC and did not fit 
into any of the 5 factors. “Shooting” and “electric shock” were both removed as 
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they both appeared to assess the same pain quality. “Pain evoked by contact 
with something warm” was also removed as less than 20% of participants chose 
the phrase. The final version of the NPSI consists of 12 items in total: 10 items 
are related to the descriptors of neuropathic pain symptoms (listed below) and 2 
items assess how long spontaneous ongoing and paroxysmal pain lasts, for 
example, how many pain attacks the patient had in the past 24 hours. The 10 
descriptor items are: 
• burning 
• squeezing  
• pressure pain 
• electric shocks 
• stabbing 
• evoked pain to brush 
• evoked pain to pressure 
• evoked pain to cold 
• tingling and 
• pins-and-needles 
 
An example of a question with a descriptor appearing on the NPSI is provided 
below. The question and scale for each of the descriptor terms mentioned above 
follows the same format to the one shown in the example with the underlined 
term changed for the various symptoms. 
 
Q1: Does your pain feel like burning? 
No burning    0   1   2   3   4   5   6   7   8   9   10   Worst burning imaginable 
Q6: Does your pain feel like stabbing? 
No stabbing    0   1   2   3   4   5   6   7   8   9   10   Worst stabbing imaginable 
 
 [Extracted from the NPSI by Bouhassira and colleagues (2004)]. 
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The NPSI is a general assessment tool for neuropathic pain intensity and after 
the NPSI is completed, a total intensity score out of 100 is calculated. The total 
pain intensity score is calculated by adding up the intensities for the seven 
neuropathic pain symptoms and the three items related to evoked pain. The 
greater the calculated score on the NPSI, the greater the severity of the pain 
experienced by patients.  
 
This study showed that the NPSI is a valid and reliable tool for assessing 
neuropathic pain, and the validity of the NPSI was further supported by a factor 
analysis performed on data obtained from 111 patients who filled out the NPSI on 
a second visit, approximately 1 month later. The factor analysis produced 5 
factors that were similar to the 5 factors obtained from the 176-patient data. The 
NPSI was translated from French into English using the forward-backward 
translation process; however, this version has not yet been validated in patients 
who speak English (Bouhassira et al., 2004).  
 
1.3.6 Douleur Neuropathique en 4 questions/ neuropathic pain diagnostic 
questionnaire (DN4) 
The neuropathic pain diagnostic questionnaire (DN4) was developed by 
Bouhassira and colleagues in 2005, and was developed in French (Bouhassira et 
al., 2005). The DN4 is a diagnostic tool for neuropathic pain and was developed 
as the other neuropathic pain diagnostic tools were not available in French. As a 
diagnostic tool, the DN4 assesses signs and symptoms of neuropathic pain.  
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1.3.6.1 Development and validation of theDN4 (Bouhassira et al., 2005) 
The items on the questionnaire were extracted from the literature, and also based 
on clinical experience of the authors. The questionnaire assessed the symptoms 
(based on interviews with participants) and signs (based on clinical examination) 
of patients with neuropathic pain. The initial questionnaire consisted of nine 
symptom descriptors and eight items related to clinical examination. The nine 
symptom descriptors were “burning, squeezing, painful cold, electric shock, 
lancinating, pins-and-needles, tingling, numbness” and “itching.” The clinical 
examination items included hypoesthesia to touch, prick, heat and cold and pain 
evoked by brushing, pressure, contact with cold and contact with heat.   
 
One-hundred and sixty patients, with central or peripheral neuropathic pain and 
non-neuropathic pain, participated in the validation study. Participants attended 
two screening sessions, separated by approximately three days. Two different 
investigators carried out the screenings on the separate days and no treatment 
was administered after the first visit. The first investigator diagnosed participants 
with neuropathic or non-neuropathic pain using standard clinical diagnostic 
criteria. Thereafter, in an interview, the DN4 questionnaire was read out to 
patients. During the second visit, the second investigator carried out the 
procedure in a similar manner. Treatment was administered to patients after the 
second visit.  
 
Factor analysis was performed and yielded 9 factors. Hypoesthesia to touch, 
prick, heat and cold were included in factor 1, factor 2 included evoked pain due 
to brushing, contact with cold and contact with heat, factor 6 included tingling and 
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pins-and-needles and all other factors included a single remaining item. Logistic 
regression modelling was performed after factor analysis and seven items were 
not included in this analysis. “Squeezing, lancinating” and “pain increased by 
pressure” were removed as the prevalence of these was similar in patients with 
neuropathic pain and non-neuropathic pain. Hypoesthesia to heat, hypoesthesia 
to cold, pain increased by heat and pain increased by heat cold were removed as 
they had a high inter-relation coefficient with other items on the list as found in 
the factor analysis. Logistic regression modelling analysis and receiver operating 
characteristic (ROC) curves were performed to determine if the remaining 10 
items were effective in distinguishing neuropathic pain from non-neuropathic 
pain.  
 
A minimum score of 4 out of 10 was obtained from this analysis as the required 
score to distinguish between the pain states. In addition, the same tests were 
used to analyse the 7 items related to symptoms to determine if the items could 
differentiate neuropathic pain from non-neuropathic pain and a score of 3 out of 
10 was obtained as the minimum score to distinguish between the two pain 
states. The final version of the DN4 thus has 10 items in total: 7 items are related 
to the symptoms of neuropathic pain and are shown below:       
 
Question 1: Does the pain have 1 or more of the following characteristics? 
 
YES NO 
1. Burning      
  
2. Painful cold 
  
3. Electric shocks 
  
 
Question 2: Is the pain associated with one or more of the following 
symptoms in the same area? 
 
YES NO 
4.Tingling 
  
5. Pins-and-needles 
  
6. Numbness 
  
7. Itching 
  
[Extracted from the DN4 Questionnaire by Bouhassira and colleagues (2005)]. 
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The remaining three items are related to the clinical examination: hypoesthesia to 
touch, hypoesthesia to prick and pain evoked or increased by brushing 
(Bouhassira et al., 2005). For all 10 items, a “yes” response renders a score of 1 
and a “no” response renders a score of 0. The total is then calculated and a score 
of equal to or greater than 4 out of 10 suggests pain of neuropathic origin. As 
with the NPSI, the DN4 was translated into English, but has not yet been 
validated in English-speaking patients (Bouhassira et al., 2005). 
 
1.3.7 ID Pain  
The ID Pain screening tool was developed in 2006 by the ID Pain Steering 
Committee and was developed to distinguish neuropathic pain from pain that is 
nociceptive in origin (Portenoy, 2006). ID Pain was developed as existing 
questionnaires (LANSS Pain Scale, S-LANSS, NPS, NPQ and DN4) were not 
being used in the primary care setting and the authors felt that there was a need 
for a simple, easily administered screening tool that could be used in the primary 
care setting.  
 
The initial list of terms was sourced from existing neuropathic pain assessment 
questionnaires and from the experience of the clinicians present on the ID Pain 
Steering Committee. This initial list of 120 items relating to the characteristics and 
symptoms of neuropathic pain was reviewed for repetitive or unclear items. After 
elimination of these terms, a list of 89 items was used in the studies to follow 
(Portenoy, 2006).   
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The ID Pain screening tool consists of six items and was developed in two 
stages. The first stage comprised of the reduction and construction of the 89-item 
list into the ID Pain screening tool and the second stage tested the validity and 
reliability of the ID Pain screening tool (Portenoy, 2006).  
 
1.3.7.1 The development and validation of the ID Pain screening tool (Portenoy, 
2006) 
The first stage consisted of 586 adult patients who had non-headache pain for at 
least 30 days. Patients filled out the 89-item list of words and approximately 2 
weeks thereafter were referred to a pain specialist who classified the patients as 
having neuropathic pain, nociceptive pain or pain of mixed etiology. The data 
obtained from the 89-item questionnaire was subjected to a univariable logistic 
regression and from this analysis, 65 items were retained for further analysis 
while an exploratory factor analysis followed by a logistic regression also retained 
65 items for further analysis (55 of these 65 items were the same for the 
univariable logistic regression and factor analysis). Both sets of 65 items were 
subject to a model building stage that produced 2 sets of items that could be 
used in the final scale. A stepwise analysis and best subsets analysis yielded 23 
items that again underwent statistical analysis and re-examination of the steering 
committee to create the 6-item ID Pain scale. Items relating to numbness and 
touch were included as the steering committee felt that these items were 
expected to distinguish nociceptive pain from non-nociceptive pain. 
 
The steering committee chose the scoring method of -1 to 5 on the ID Pain and 
the scores for each item on the tool were calculated using a ROC curve, with 
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scores of 3, 4 and 5 indicating pain of neuropathic origin. This screening tool 
does not take into account measures of pain intensity or other qualities of pain 
and is therefore not classified as a multidimensional screening tool for 
neuropathic pain. This tool is a simple, time-efficient tool for neuropathic pain 
diagnosis and can be self administered by patients but, it does not include an 
assessment of signs. In addition to the pain items on the tool, there is a body 
chart requesting patients to shade in the areas where pain is felt. The ID Pain 
screening tool is presented below: 
Question Score 
Yes No 
1. Did the pain feel like pins-and-needles? 1 0 
2. Did the pain feel hot/burning? 1 0 
3. Did the pain feel numb? 1 0 
4. Did the pain feel like electric shocks? 1 0 
5. Is the pain made worse with the touch of clothing or bed 
sheets? 1 0 
6. Is the pain limited to your joints? -1 0 
 
    [The ID Pain screening tool by Portenoy and colleagues (2006)].    
 
Data from 308 patients (neuropathic, nociceptive and mixed pain), who did not 
participate in the first stage of the study, were used in the validity and reliability of 
the 6-item scale. Patients were asked to fill out a series of questionnaires: the 6-
item scale, the modified Brief Pain Inventory, the Hospital Anxiety and 
Depression Scale and the global anxiety VAS. Approximately 5 to 10 days later, 
patients were asked to fill out the 6-item scale as well as the modified Brief Pain 
Inventory.  The most frequent terms used to describe all three types of pain and 
the most common physical findings in this part of the study are shown in Table 
1.1.  Using data from the second stage of the study, an ICC and kappa statistic 
showed that the score indicating nociceptive pain was 1, a score indicating mixed 
pain was 2 and a score of 3 or more indicated pain of neuropathic origin. 
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Table 1.1: The most common terms used to describe neuropathic, mixed and 
nociceptive pain and the most common physical findings amongst all three pain 
groups in stage one of the validation study for the ID pain screening tool. 
 
Neuropathic 
pain patients 
(n=105) 
Mixed pain 
patients (n=104) 
Nociceptive 
pain patients 
(n=99) 
Burning/aching/ 
stabbing 
84% 86% 74% 
Numbness 71% 63% 42% 
Tingling 67% 59% 43% 
Pain on motion 45% 67% 76% 
Sensitivity to pin-prick 74% 44% 32% 
 
 
1.3.8 The Brief Peripheral Neuropathy Screen (BPNS)  
Although the Brief Peripheral Neuropathy Screen (BPNS) (Cherry et al., 2005) is 
not a semantic tool for neuropathic pain, a short summary of the BPNS will be 
provided as the tool was used to screen participants for a neuropathy in the 
present study. The BPNS was derived from the Subjective Peripheral Neuropathy 
Screen (SPNS) (McArthur, 1998) and will therefore be briefly described first. 
 
1.3.8.1 The Subjective Peripheral Neuropathy Screen (SPNS) (McArthur, 1998) 
McArthur (1998) tested the validity of the Subjective Peripheral Neuropathy 
Screen (SPNS) as a tool that could correctly diagnose peripheral sensory 
neuropathies in HIV patients.  She compared the SPNS to quantitative sensory 
testing (QST) methods as a means of detecting neuropathy in HIV positive 
patients with peripheral sensory neuropathy and in HIV patients without a 
peripheral neuropathy (McArthur, 1998). The SPNS consists of three symptom 
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items (pain/burning/aching, pins-and-needles and numbness) located in the 
hands and arms or in the feet and legs and patients were required to rate the 
severity of these symptoms. The results showed that the severity scores on the 
SPNS were significantly correlated to measures obtained from the vibratory 
component on the QST and, the SPNS was found to be a reliable and validated 
tool for detecting peripheral neuropathy in HIV patients. The study by McArthur 
also showed that the symptoms felt in the hands could not distinguish between 
patients with neuropathy and those without and the component relating to the 
symptoms in the hands could be removed (McArthur, 1998).      
 
1.3.8.2 Validation of the BPNS for use in HIV-associated sensory neuropathy 
The BPNS is very similar to the SPNS with additional components involving 
clinical examinations to detect possible neuropathy. The BPNS is commonly used 
in AIDS Clinical Trial Group (ACTG) studies and is also referred to as the ACTG 
neurological screening tool (Cherry et al., 2005). In its standard form, the 
symptom screen involves participants identifying whether symptoms in their feet 
and legs feel like: “burning or aching”, “pins-and-needles”, or ““numbness (lack of 
feeling)”. If the participant has one or more of the symptoms, they rate the 
intensity of each of the symptoms on an 11-point numerical symptom rating scale 
ranged from 0 (no symptoms) to 10 (severe). The clinical examinations include 
testing for a reduced or absent ankle reflex using a reflex hammer and a 
decreased vibration sense in the patient’s big toe. The bilateral presence of 
symptoms and signs of peripheral neuropathy is required for a diagnosis of HIV-
SN to be made.  
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In 2005, Cherry and colleagues wanted to assess and validate the properties and 
practicality of the BPNS for use in diagnosing sensory neuropathies in HIV 
infected individuals (Cherry et al., 2005). They compared the BPNS against more 
time consuming methods for the diagnosis of HIV-SN, namely, QST and 
intraepidermal nerve fiber density measures.  The participants’ vibration and 
thermal thresholds were tested in the QST method using computer software. For 
the intraepidermal nerve fiber density measures, a skin biopsy of 3mm from the 
lateral side of the distal calf was collected and analysed according to standard 
methods (Cherry et al., 2005). The results showed that the tool has a specificity 
of 98% and a sensitivity of 84% for a reduced or absent ankle reflex. This clinical 
sign was related to a high sensory threshold from the QST and a lower 
intraepidermal nerve fiber density. The presence of numbness had a specificity of 
81%, a sensitivity of 86% and the degree of severity was associated with high 
sensory threshold from the QST and a lower intraepidermal nerve fiber density in 
the distal calf (Cherry et al., 2005).   
 
The tool has thus been validated for the diagnosis of HIV-SN, and is commonly 
used in South Africa for the clinical diagnosis of HIV-SN in research and medical 
practices. However, it remains unknown if South African patients, who do not 
speak English as a first-language, truly understand the symptom terms listed on 
the BPNS.   
 
1.3.9 A summary of the questionnaires 
Table 1.2 shows a summary of all the questionnaires listed in this section. The 
development of the questionnaires has been ongoing for the last two decades 
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and the need for such questionnaires to assist clinicians with the assessment and 
correct diagnosis of neuropathic pain and early treatment of the condition cannot 
be stressed upon enough.  These questionnaires are important in assisting 
researchers involved in epidemiological research and those who are interested in 
the symptom measures of neuropathic pain. The development and validation of 
such a vast range of assessment and diagnostic tools suggest that neuropathic 
pain is indeed difficult and problematic to diagnose and evaluate.  
 
Table 1.2: A summary of the pain assessment and diagnostic questionnaires.   
 MPQ (SF-MPQ) NPS LANSS S-LANSS 
Year of 
development 1975 (1987) 1997 2001 2005 
Language of  
development English (English) English English English 
Number of 
symptom items 78 (15) 10 7 7 
 
 
 
 
 
 
 
Symptom 
items 
 
 
 
 
*Sensory items 
   Throbbing 
   Shooting 
   Stabbing 
   Sharp 
   Cramping 
   Gnawing 
   Hot or burning 
   Aching 
   Heavy 
   Tender 
   Splitting 
Affective items           
  Tiring/exhausting 
  Sickening 
  Fearful 
  Punishing/cruel 
Sharp 
Dull 
Sensitive 
Deep pain 
Hot 
Cold 
Itchy 
Surface pain 
Pricking, 
tingling or pins-
and-needles 
Electric shocks, 
jumping or 
bursting 
Hot or burning 
 
Pain caused by 
light touching 
 
+ 2 clinical 
examination 
items 
Pricking, 
tingling or 
pins-and-
needles 
Electric 
shocks, 
jumping or 
bursting 
Hot or 
burning 
 
Pain caused 
by light 
touching 
 
+ 2 clinical 
examination 
items 
Self- 
administered No Yes No Yes 
Symptoms/ 
clinical 
examination 
Symptoms Symptoms Both Both 
Diagnostic/ 
assessment 
tool 
Both Assessment Diagnostic Diagnostic 
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NPQ NPSI DN4 ID-Pain BPNS 
Year of 
development 2003 2004 2005 2006 2005 
Language of 
development English French French English English 
Number of 
symptom  
Items 
12 12 10 6 3 
 
 
 
 
 
 
 
 
 
 
 
Symptom items 
 
 
Burning 
Overly 
sensitive to 
touch 
Shooting 
Numbness 
Electric 
Tingling 
Squeezing 
Freezing 
 
How 
unpleasant 
is the pain? 
 
Increased 
pain due to 
touch 
 
Increased 
pain due to 
weather 
changes 
 
Burning 
Squeezing 
Pressure pain 
Electric 
shocks 
Stabbing 
 
Evoked pain 
to brush 
 
Evoked pain 
to pressure 
 
Evoked pain 
to cold 
 
Tingling 
Pins-and-
needles 
 
 
Burning 
Painful cold 
Electric 
shocks 
Tingling 
Pins-and-
needles 
Numbness 
Itching 
 
+ 3 clinical 
examination 
items 
Pins-and-
needles 
Hot or 
burning 
Numb 
Electrical 
shock 
Is pain 
made worse 
with touch? 
Burning/ 
aching 
Numbness 
Pins-and-
needles 
 
+2 clinical 
examination 
items 
Self-
administered Yes Yes No Yes No 
Symptoms/ 
clinical 
examination  
Symptoms Symptoms Both Symptoms Both 
Diagnostic/ 
assessment 
tool 
Both Assessment Diagnostic Diagnostic Diagnostic 
  
*The pain symptoms found on the SF-MPQ. 
Note: only terms used to describe pain symptoms or questions pertaining to the stimuli 
that may evoke pain are shown in Table 1.2. MPQ=McGill Pain Questionnaire; SF-
MPQ=short form MPQ; LANSS=Leeds Assessment for Neuropathic Symptoms and Signs 
Pain Scale; S-LANSS=self-completed LANSS; NPQ=Neuropathic Pain Questionnaire; 
NPSI=Neuropathic Pain Symptom Inventory; DN4=neuropathic pain diagnostic 
questionnaire; BPNS=Brief Peripheral Neuropathy Screen.    
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Most of the above-mentioned questionnaires have been adapted and validated in 
other languages and were translated using either a forward-backward translation 
method only, while others were developed using a reconstruction-based method 
(Stein and Mendl, 1988; Boureau et al., 1992; Perez et al., 2007; Koc and 
Erdemoglu, 2010; Van Seventer et al., 2010). In the forward-backward translation 
procedure, terms are forward-translated into the language concerned and then 
back-translated into English by a different translator to ensure authenticity of the 
translation (Van Seventer et al., 2010). Briefly, a reconstruction-based method 
involves translating the terms and then reconstructing the questionnaire by 
excluding, including or rephrasing other items that are well understood by the 
population being studied, making it language and culturally specific. More detail 
on the forward-backward translation and reconstruction-based methods will be 
provided shortly, when the guidelines that should be followed when creating or 
translating questionnaires are mentioned.  
 
The MPQ has been translated and validated in Portuguese (Varoli and Pedrazzi, 
2006), German (Kiss et al., 1987; Stein and Mendl, 1988) and Italian (De 
Benedittis et al., 1988), amongst others. Assessments for neuropathic pain have 
also been translated into various languages: the NPS has been translated into at 
least 24 languages (Cruccu et al., 2010), the DN4 has been translated and 
validated in languages such as Portuguese (Santos et al., 2010) and Spanish 
(Perez et al., 2007), while the NPSI has been translated into 50 other languages 
(Cruccu et al., 2010) including Italian (Padua et al., 2009) and English 
(Bouhassira et al., 2004). The LANSS and S-LANSS have both been translated 
into Turkish (Yucel et al., 2004; Koc and Erdemoglu, 2010). Irrespective of 
language, a pain assessment or diagnostic tool should be valid and consistent 
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amongst various cultural groups and this can only be achieved if “equivalence” is 
present between the original and translated questionnaires (Herdman et al., 
1997); however, the translation of questionnaires may be prone to a few 
problems. 
 
1.3.10 The pitfalls of translating questionnaires into other languages 
Language-appropriate questionnaires should lead to improved and correct 
diagnosis of neuropathic pain and will provide data that is accurate for use in 
clinical and epidemiological studies. None of the questionnaires, specific and 
non-specific to neuropathic pain, have been translated or validated in languages 
that are spoken by majority of the South African population.  A few 
questionnaires, such as the SF-MPQ, NPS and NPSI have been translated, but 
not validated, into Afrikaans (PROQOLID, 2009; PROQOLID, 2011a; 
PROQOLID, 2011b) and there are currently no questionnaires in an African 
language. Language is complex, and the differences in syntax, context and 
grammar play an essential role in translating questionnaires into a different 
language to ensure that it reads correctly and is well understood. The easiest 
way to translate existing questionnaires into a new language may be to directly 
translate it. However, many problems occur when questionnaires are translated 
into other languages as Mkoka and colleagues (2003) illustrate in their study. 
 
Mkoka and colleagues (2003) tested the forward and back-translation of an 
isiXhosa version of the European Quality of Life 5-dimensions (EQ-5D) 
questionnaire. The questionnaire was forward-translated into isiXhosa by 
translators fluent in both isiXhosa and English (Mkoka et al., 2003). The back-
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translation was carried out by a similar group of translators and a draft of the 
isiXhosa version was tested in nine isiXhosa-speaking subjects. In the translation 
process, it was found that a few words could not be directly translated into 
isiXhosa as the backward translation of these words proved. The word “mobility” 
on the EQ-5D was difficult to translate as the isiXhosa equivalents were back-
translated as, for example, “movement of any object.” After much thought, the 
term “ukuhamba-hamba” was suggested but back-translation of this term 
emerged as “casual sex.” It was then decided that the isiXhosa equivalent to be 
used was “ukuhamba” which literally means “to walk.” Although “ukuhamba” does 
not sufficiently suggest mobility as such, it was the closest word that suggested a 
state of mobility (Mkoka et al., 2003). 
 
Guillemin and colleagues (1993) mention two ways of creating questionnaires in 
a different language that will take into account cultural differences. The first 
method consists of creating a new questionnaire entirely or, the second method 
includes translating a questionnaire by following the correct guidelines to ensure 
that it is relevant and correct for different cultures. The second method is known 
as “cross-cultural adaptation” and is a reconstruction-based method for 
translating questionnaires  (Guillemin et al., 1993). In their paper “Cross-cultural 
adaptation of Health-related Quality of Life Measures: literature review and 
proposed guidelines,” Guillemin and colleagues suggest guidelines that should 
be taken into account when translating existing questionnaires. 
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Their guidelines include five basic steps (Guillemin et al., 1993):  
i) Forward-translation of the questionnaire. This step should be completed by at 
least two different translators, who are qualified in the field, 
 
ii) Back-translation of the translated terms. This stage should be completed as 
many times as was completed in the forward-translation process. Appropriate 
translators should be used and should include those who are not only fluent in 
the language, but can also identify common colloquial and idiomatic phrases in 
the language,   
 
iii) Review of the questionnaire by an expert committee. A group of experts 
should be recruited to create the final version of the questionnaire. The 
committee should review the terms and phrases on the translated list and should 
modify them, reject those that are irrelevant and create new ones if necessary. 
They should also ensure that the new questionnaire reaches complete 
equivalence with regards to language and culture. Generally the following four 
“equivalences” should be looked at: semantic, idiomatic, experiential and 
conceptual. Each of these “equivalences” will be discussed in detail in the 
paragraphs that follow. 
  
Semantic equivalence is achieved when words in the different languages have 
the same meaning. In some instances achieving the same meaning may result in 
grammar and vocabulary discrepancies.  
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Idiomatic equivalence is sometimes hard to achieve as idioms and colloquialisms 
cannot be translated or are difficult to translate into a different language as they 
lose their essence.   
 
Experiential equivalence refers to using sentences with examples that are 
common to the target population’s everyday lifestyle and experiences. When 
Mkoka and colleagues (2003) aimed to translate the sentence “confined to bed” 
on the EQ-5D, they found it difficult as firstly, it assumed that all the participants 
slept on actual beds and thus experiential equivalence is not achieved in this 
instance. Secondly, the isiXhosa idiom “ukulala ngendlu” translated as “lying in 
the house,” could not be used due to semantic differences (Mkoka et al., 2003).    
 
Conceptual equivalence is based on the equality of concept. In other words, a 
word may have semantic equivalence but there may be differences with regards 
to concept. As an example, when Mkoka and colleagues (2003) attempted to 
translate the word “male” into isiXhosa, they found that there was a difference 
between boys and men that was not related to age groups but rather a cultural 
difference that was based on initiation. “Indoda” (male) could thus not be used in 
the questionnaire as a boy who was not initiated could not be called an “indoda.” 
The authors then found a word that could aptly apply to a mature male and used 
this form instead (Mkoka et al., 2003).  
 
iv) Pre-testing the questionnaire for equivalence involves asking participants to fill 
out the newly translated and adapted questionnaire to ensure that the above-
mentioned equivalences are reached, and, 
50 
 
v) Re-examination of weighting scores. The final step uses statistical methods in 
order to determine the most appropriate manner of combining all the information 
on the new questionnaire.   
 
Cross cultural adaptation of existing questionnaires thus requires two phases; the 
translation phase and the adaptation phase to ensure that it is reliable and 
validated, not only with regards to language, but in a cultural context as well. 
Although cross-cultural adaptation does not consume much time and is more cost 
effective than developing a new questionnaire, it still requires invaluable time, 
dedication and numerous people and stages of development (Guillemin et al., 
1993). As none of the neuropathic pain assessment tools and diagnostic 
questionnaires have been translated in a South African population, the need for a 
study to do so is apparent due to the vast linguistic and cultural differences that 
exist between different individuals.   
 
1.4 SIGNIFICANCE OF STUDY AND OBJECTIVES FOR CURRENT STUDY 
1.4.1The need to measure neuropathy conditions in South Africa 
Is there a problem using English-based neuropathic pain questionnaires in South 
Africa? Firstly, South Africa has one of the largest populations of HIV infected 
individuals with a prevalence rate of approximately 10.5% (Census, 2001). From 
the 33 million people infected with HIV worldwide, approximately 5.4-5.8 million 
are South Africans (UNAIDS, 2010).  At almost every stage of HIV infection, 
peripheral neuropathy remains the most frequent neurological disorder (Ferrari et 
al., 2006; Arasho et al., 2008). Patients with HIV-SN present with painful feet, 
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often described as “burning” or ”aching” and some patients may present with 
pins-and-needles or numbness and the management of HIV-SN is centred on 
treating these symptoms (Ferrari et al., 2006; Arasho et al., 2008; Wadley et al., 
2011). In the South African population, the prevalence of symptomatic HIV-SN is 
approximately 57% (Wadley et al., 2011). Wadley and colleagues (2011) found, 
in their study, that pain was present in approximately 76% of South African 
participants with HIV-SN, pins-and-needles in 46% of participants and 48% of 
participants experienced numbness in their feet.  
 
Secondly, neuropathic pain is not limited to individuals with HIV and in South 
Africa, diabetes affects approximately 3.9% of the population (the results are 
adjusted for age and based on the prevalence of diabetes in South Africans from 
a rural community of Zulu ancestry) (Motala et al., 2008). Diabetes can affect any 
part of the nervous system and the most frequent neuropathy in diabetic patients 
is distal symmetric polyneuropathy (DSP) (Boulton et al., 2005). DSP is a chronic 
condition, affects the lower limbs and feet more than it affects the hands and is 
present in approximately 50% of diabetic patients (Boulton et al., 2005). Pain and 
sensations described by patients with DSP include “burning, aching, sharp pain, 
electric-like or shooting pain”, and “numbness” (Bhadada et al., 2001; Boulton et 
al., 2004; Boulton et al., 2005).  
 
1.4.2 Assessing neuropathic pain in South Africa 
With the numbers of HIV infected and diabetic individuals increasing in South 
Africa daily, it is important that health care practitioners are able to detect and 
diagnose peripheral neuropathy early to initiate treatment strategies immediately. 
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However, it may be challenging for practitioners to detect the early signs and 
symptoms of peripheral neuropathy and manage the pain if patients cannot fully 
express themselves or complete standardized questionnaires because of 
language barriers.  
 
In addition, investigators who have previously carried out neuropathy studies in a 
South African population may have experienced problems when trying to 
communicate with participants who did not speak English as a home-language. A 
study testing the usage and understanding of neuropathic pain descriptors in 
individuals of African ancestry whose home-language is isiZulu and who are not 
fluent in English is needed to assist practitioners, health care providers, patients 
and researchers.  
 
As cultural and racial differences exist in pain perception, experience and 
management, it is important to measure and assess neuropathic pain in South 
Africa, as such information will contribute to the understanding of neuropathic 
pain in individuals of African ancestry. To date, no such study has been 
conducted in South Africa. Therefore, the objectives of this study were to 
determine what terms are used by isiZulu speakers to describe their neuropathic 
pain symptoms and to determine the level of understanding of terms on English-
based neuropathic pain questionnaires that are used to diagnose and assess 
neuropathic pain in South African patients whose home-language is not English. 
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The objectives of the present study were as follows: 
i) to determine the words used by isiZulu speakers to spontaneously 
describe their neuropathic pain symptoms, 
 
ii) to determine the understanding of English neuropathic pain descriptors 
found in commonly used neuropathic pain questionnaires, 
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CHAPTER 2 
METHODOLOGY 
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The study was approved by the Human Research Ethics Committee (Medical) of 
the University of the Witwatersrand (clearance number: M090669), and written 
informed consent was obtained from all participants. An interpreter fluent in 
isiZulu facilitated the recruitment, consent and interview procedures.  
 
2.1 PARTICPANTS 
Sixty-nine participants (47 females and 22 males) were recruited from the 
Virology Clinic at Charlotte Maxeke Johannesburg Academic Hospital, 
Johannesburg, South Africa. Participants were invited to participate in the study if 
they currently were experiencing any pain or abnormal sensations in their feet 
and lower legs, they had been on stable antiretroviral therapy for at least one 
month, and they spoke isiZulu as their primary language. We defined primary 
language as the participant’s preferred language of communication when 
conversing with family and friends. If participants met the inclusion criteria, they 
were screened for the presence of peripheral sensory neuropathy using the 
BPNS generally used in ACTG studies (Cherry et al., 2005). If peripheral 
neuropathy was present, participants were asked to partake in the interview 
component of the study.  
 
2.1.1 Exclusion criteria 
From the 69 participants initially recruited, 15 were excluded from the study: 3 
participants did not have peripheral neuropathy, and 12 did not meet the criteria 
of isiZulu being their primary language. Thus, the final cohort consisted of 54 (38 
females and 16 males) South African participants with HIV-SN.  
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2.2 SCREENING FOR NEUROPATHY 
The BPNS was used to diagnose the presence of HIV-SN. To avoid priming 
patients with English-language descriptors of neuropathic pain during the 
screening process, we changed the symptom screen of the tool to ask only 
whether the individual had pain or unusual feelings in their feet and lower legs, 
and if so, to rate their intensity of the symptom as mild, moderate or severe. The 
modified version of the screening tool is presented in Appendix 2.  
 
No changes were made to the screening tool for the assessment of signs of 
neuropathy. Ankle reflexes were evaluated using a reflex hammer that was struck 
against the Achilles tendon while the examiner observed for the presence of a 
reflex movement of the foot. If no reflex could be elicited, the individual was 
asked to reinforce the reflex by clenching their fists while the tendon strike was 
repeated. The reflex was recorded as being absent only after failure to elicit a 
reinforced reflex. Vibration sense was assessed using a 128 Hertz tuning fork. 
Before assessing vibration sense in the feet, individuals were familiarized with the 
vibration sensation by striking the tuning fork and placing it on the individual’s 
wrist. Once they were familiar with the sensation, the tuning fork was struck again 
and placed on the distal interphalangeal joint of the big toe and the time taken for 
the participant to cease perceiving the vibration was measured in seconds using 
a stopwatch. A deficit in vibration sense was recorded if the duration of sensation 
from the time the tuning fork was struck to when the individual reported they 
could no longer perceive the vibration was less than ten seconds. The ankle 
reflex and vibration sense testing procedures were repeated on both legs. 
Participants had to present with symptoms (pain and/or abnormal sensations) 
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and at least one sign in both legs to be diagnosed with HIV-SN. All neuropathy 
assessments were performed by the researcher, and to ensure quality control in 
the screening process, the researcher was trained in the procedure prior to 
commencing the study, and the trainer verified the researcher’s diagnosis at 
random times during the study. 
 
In participants diagnosed with HIV-SN, additional information on the participant’s 
HIV disease (CD4 T-cell count, date of HIV diagnosis) and treatment (current and 
previous antiretroviral drug use) history, and whether they had additional risk 
factors for developing a peripheral neuropathy (e.g., diabetes mellitus, alcoholism 
and tuberculosis infection), was obtained from their medical records. The 
participant’s age, gender, ancestry and highest level of schooling was obtained 
by asking the participants for the information.  
 
2.3 THE INTERVIEW 
After meeting the inclusion criteria for the study, participants had an interview 
which consisted of the following components: 1. A spontaneous description by 
participants, in isiZulu, of the pain and abnormal sensations in their lower legs 
and feet and what triggered the sensations. Participants were not prompted 
during this spontaneous description, but were encouraged to give a complete 
description of all the sensations and triggers for the sensations.    
 
2. A list of commonly used English neuropathic symptom descriptors was read to 
participants and they were asked to identify which terms accurately described 
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their pain. Before the list was read, it was made clear to all participants that the 
descriptive words about to be read to them referred to the pain and sensations in 
their feet and lower legs only. Participants were required to answer “yes, I have 
the symptom,” “no, I do not have the symptom” or “I do not understand what the 
word means” after each term was read to them. For the words they selected, they 
were immediately asked to provide an equivalent isiZulu term for the English 
description.  
 
An example of how this second component of the interview process proceeded is 
provided below: 
Interviewer: “Does the pain in your feet and lower legs feel like an electric-shock                          
or electric like?”     
Participant: “No”  
Interviewer: “Does the pain feel knife-like or stabbing?” 
Participant: “Yes” 
Interviewer: “And how would you describe the stabbing pain in isiZulu?” 
Participant: “Ziyahlaba” 
Interviewer: “Does your pain feel like pins-and-needles?” 
Participant: “I don’t understand” 
 
Each interview was recorded using a digital camcorder (Sony Handy-cam DCR-
SX40E (PAL), Sony Corporation, South Africa). However, as most of the 
participants were uncomfortable with their faces being recorded, the lens of the 
camcorder was turned away from participants and only the audio component of 
the interview was recorded. The interview lasted approximately 20 minutes and 
participants were offered refreshments during the interview.  
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2.4 DEVELOPMENT OF THE ENGLISH WORDLIST OF NEUROPATHIC 
SYMPTOM DESCRIPTORS 
The inventory of English terms we used to describe the symptoms of neuropathy 
was constructed from terms commonly used to describe neuropathy symptoms in 
the English-language versions of the McGill Pain Questionnaire (Melzack, 1975), 
Neuropathic Pain Scale (Galer and Jensen, 1997), the Leeds Assessment of 
Neuropathic Symptoms and Signs (Bennett, 2001), Neuropathic Pain 
Questionnaire (Krause and Backonja, 2003), Neuropathic Pain Symptom 
Inventory (Bouhassira et al., 2004), Neuropathic pain diagnostic questionnaire 
(Bouhassira et al., 2005) and the ID Pain screening tool (Portenoy, 2006). Other 
neuropathic symptom descriptors that were not found on the neuropathic pain 
assessments listed above, were obtained from research publications pertaining to 
neuropathic pain and were included in the list.  
 
To determine if the primary wordlist was appropriate for the study, a pilot study 
was performed on the first three participants who were willing to partake in the 
interview. The methodology for the pilot study followed the procedure mentioned 
above (2.3 The Interview). The pilot interviews showed that the words “bursting, 
strange/unusual, squeezing, dull, intense, lancinating, gnawing, splitting, piercing, 
tender” and “sensitive” were not understood by any of these participants, and this 
caused the participants to becoming visibly embarrassed by their lack of 
understanding of so many terms. Thus, the initial wordlist of 33 words and 
phrases was reduced to 21 items as the certain terms that patients did not know 
the meaning to, were removed from the list (Table 2.1). The terms cold and 
freezing were combined after the first three interviews because the participants 
60 
 
could not distinguish between the two words. In addition, completing the list of 33 
words was time consuming and participants became agitated towards the end of 
the lengthy interview as they needed to see their physician or collect their 
medication from the pharmacist.  
 
Table 2.1: The development of the English-language neuropathic symptom 
wordlist read to participants during the interview. 
 
 
 
Terms in initial list Terms in final list Source of terms (references) 
 1 Electric shock/electric 1. Electric shock/electric 2,3,4,5,7,8,10 
2 “Knife-like”/stabbing 2. “Knife-like”/stabbing 1,3,8,9 
3 Pins-and-needles 3. Pins-and-needles 3,4,5,7,8,9 
4 Bursting*  5 
5 Tight 4. Tight 1 
6 Strange/unusual*  6 
7 Hot 5. Hot 1,4,6 
8 Burning 6. Burning 1,2,3,4,5,7,8,9 
9 Cold 7. Cold/Freezing 1,6,7,10 
10 Freezing  1,2 
11 Tingling 8. Tingling 1,2,3,5,7,8,9 
12 Pricking 9. Pricking 1,5 
13 Jumping 10. Jumping 1,5 
14 Shooting 11. Shooting 2,8,9,10 
15 Numb 12. Numb 1,2,4,6,7,8,9 
16 Squeezing*  2, 3 
17 Itching 13. Itching 1,6,7,8 
18 Evoked by heat 14.Caused by heat (e.g. A hot bath) 2,8 
19 Evoked by cold 15. Caused by cold (e.g. on a cold day or after 
a cold bath) 
2,8 
20 Evoked by pressure 16. Caused by pressure/ touching the skin 
(e.g. blankets/socks) 
2,3,4,7,8,10 
21 Aching 17. Aching 1,9 
22 Dull*  1,6 
23 Intense*  1,6 
24 Throbbing 18. Throbbing 1,8 
25 Lancinating*  1,10 
26 Gnawing*  1 
27 Splitting*  1 
28 Piercing*  1 
29 Cramping 19. Cramping 1 
30 Sharp 20. Sharp 1,6,9 
31 Tender*  1,5 
32 Sensitive*  2 
33 Radiating 21. Radiating 1 
*the terms from the initial list that were removed as they were the least understood terms. 
The words in the first column are all the words initially chosen for the wordlist, the list of words in the second 
column are the words in the final version of the questionnaire that was read to participants during the interview. 
The citation numbers in the third column refer to the source from which the words were obtained: 1: Melzack, 
1975 (McGill Pain Questionnaire), 2: Krause and Backonja, 2003 (Neuropathic Pain Questionnaire), 3: 
Bouhassira et al., 2004 (Neuropathic Pain Symptom Inventory), 4: Portenoy, 2006 (ID Pain), 5: Bennett, 2001 
(Leeds Assessments for Neuropathic Pain Symptoms and Signs), 6: Galer and Jensen, 1997 (Neuropathic Pain 
Scale), 7: Bouhassira et al., 2005 (neuropathic pain diagnostic questionnaire), 8: Dworkin, 2002 9: Mendell and 
Sahenk, 2003, 10: Cruccu et al., 2004. 
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2.5 DATA ANALYSIS 
All audio recordings were transcribed and all isiZulu sections of the transcriptions 
were translated into English by a professional translation service (Perfect 
Transcribers, Braamfontein, Johannesburg), as well as by the interpreter who 
assisted with data collection. In all cases, the two independent translations were 
compared, and where the translations differed, both translators were consulted 
and a consensus translation agreed on.  
 
Descriptive statistics and content analysis were used to analyse the data. We 
analysed data in the following manner: 
 
2.5.1 Spontaneous description of neuropathic symptoms in isiZulu 
We extracted all the descriptive terms and phrases used by participants to 
describe their symptoms, both in the English translation and original isiZulu, as 
well as the phrases that indicated what triggered the pain.  
 
2.5.2 Selection and understanding of English neuropathic symptom descriptors 
by isiZulu speakers 
From the list of English terms read to participants, we calculated the percentage 
of participants who chose each term to describe their neuropathic symptoms, the 
percentage who did not choose the term to describe their symptoms, and the 
percentage that declared that they did not understand the English term.  
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2.5.3 Understanding of English terms 
To confirm whether words chosen from the English list of terms were correctly 
understood by participants having the symptom, we compared the meaning of the 
English term to the meaning of the isiZulu term they gave us as being equivalent 
to the English term. If the back-translation of the isiZulu term matched the English 
term, then the participant was judged as having truly understood the English 
term. If the back-translation of the isiZulu term matched an English word that 
belongs to the same grouping of words on the MPQ, then too were participants 
judged as having truly understood the term. For example, in the punctate 
pressure group the terms “knife-like/stabbing” and “pricking” can be found. If the 
term “knife-like/stabbing” was read to a participant and they agreed that they had 
the symptom, but provided an isiZulu term that was back-translated as “pricking,” 
the participant was said to have a true understanding of the term “knife-
like/stabbing.” 
 
2.5.4 Comparison of spontaneous terms versus prompted English terms 
The descriptive terms and phrases provided during the spontaneous description 
of neuropathic pain were compared to the prompted English terms. A percentage 
concordance was calculated for each term on the English wordlist.  
 
2.5.5 Impact of pain on daily activities 
Although the impact of neuropathic pain on everyday lives was not a primary 
objective to the study, participants willingly and spontaneously provided 
information regarding this topic. We thus extracted the isiZulu phrases and the 
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English translation of those phrases, from these spontaneous verbal responses, 
which showed the impact of neuropathic pain on the participants’ lives.   
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CHAPTER 3 
RESULTS 
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3.1 DEMOGRAPHICS 
The mean age of participants was 42 yrs (SD 10yrs), and the percentage of 
females was 70%. All participants were on antiretroviral therapy for at least one 
month when interviewed, and at least 92% had been exposed to Stavudine (data 
available for 49 participants only). Ten percent of participants had a history of 
alcoholism, 37% of tuberculosis infection and 8% of diabetes mellitus. The 
median current CD4 T-cell count was 361cells/mm3 (range 35-837cells/mm3, data 
available for 42 participants only).  
 
Fifty-nine percent (n=32) of participants identified themselves as being of Zulu 
ancestry; 11% were of Xhosa ancestry, 11% were of Sotho descent and 19% had 
identified themselves as being of other ancestry, typically Tswana, Shangaan, 
Pedi or Swati. Irrespective of their self-identified ancestry, all participants spoke 
isiZulu either as a home-language or as their primary language of communication 
with their friends. Seventy-six percent (n=38) of participants had received less 
than 12 years of formal education, with the median number of  years of education 
being 10 years (inter-quartile range:8-12) (data available for 50 participants only). 
Eight-two percent (n=41) of participants had received some or completed 
secondary education (8-12 years education), 16% had received primary 
education (1-7 years education) and 2% had received no education. 
 
3.2 PAIN INTENSITY 
The intensity of foot and lower leg pain reported by participants with pain (n=51) 
is shown in Figure 3.1. The majority of participants (72%) reported experiencing 
moderate to severe pain. The remaining three participants who did not 
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expereince pain, experienced numbness and paresthesias only (not shown in 
figure 3.1).  
 
 
Figure 3.1: Pain intensity (mild pain, moderate pain and severe pain) reported by 
the 51 participants who had pain.  
 
3.3 SPONTANEOUS DESCRIPTION OF NEUROPATHIC SYMPTOMS IN 
ISIZULU 
The isiZulu terms spontaneously provided by participants when describing their 
neuropathic symptoms in their feet and lower legs are shown in Table 3.1. In 
addition, participants also provided examples of what triggered the sensations in 
their feet and lower legs. 
 
The terms “hot,” “cramping,” “itching” and “numbness” were the most common 
terms spontaneously used to describe the symptoms of neuropathy. We included 
“numbness” even if participants did not use a term for it, but if they described the 
Mild
28%
(n=14)
Moderate
37% (n=19)
Severe 
35%
(n=18)
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sensation in such a way that it indicated lack of sensation in their feet or lower 
legs. 
 
Table 3.1: isiZulu terms spontaneously used by participants to describe their 
neuropathic symptoms, and the percentage of participants who used each term.  
isiZulu term used by 
paticipants 
% participants who 
used the term* 
English translation of 
spontaneous isiZulu 
term 
Ziyashisa, Ukushisa 48 Hot 
Amajaqamba, 
Namacramps, 
Ama-cramps. 
Namajaqamba 
35 Cramping 
Phrase in text 30 Pain caused by walking 
Buhlungu, Zibabuhlungu 32 Painful/Sore 
Kuyaluma, Ziyaluma, 
Ukuluma 
22 Itching 
“N mb,” Ndikindiki 22 Numb 
Kubanda, Ziyabanda 17 Cold 
Phrase in text 17 Pain caused by 
pressure/touch 
Ziyashisa, Zinokushisa 7 Burning 
Ezihlabaya, Nziyahlaba 6 Stabbing 
Kuyahlaba, ezihlabaya 6 Pricking 
Phrase in text 4 Pain caused by cold 
Phrase in text 2 Pain caused by heat 
Kuyahlaba 2 Pins-and-needles 
*n=54 
An example of an isiZulu phrase containing the symptom “hot” from the 
spontaneous verbal responses is shown below. The phrase is shown in isiZulu, 
just as the participant described the pain and sensations, with the English 
translation in bold letters after the isiZulu. The underlined term is one of the terms 
listed in Table 3.1.  
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...njengamanje izinyawo zami ziyashisa ngaphansi. ...like right now my  
feet are hot underneath. Participant 5 
 
Participants also provided examples stating how pain may be evoked by 
pressure, touch or a thermal stimulus. Approximately 30% (n=16) of participants 
reported pain when walking: 
 
Ngathi manginyathela nginyathela ameva. It feels like I am walking on 
thorns. Participant 8 
 
Seventeen percent of participants (n=9) reported pain caused by touching the 
feet (e.g.massaging the feet or when the feet were covered with blankets): 
 
And uma mhlawumbe ziba nokuthintana neshidi uma ngilele ziba 
buhlungu. When they get into contact with a sheet they get painful. 
Participant 5 
 
A total of 4% (n=2) said that the pain was caused by a cold stimulus: 
 
Mangingahlala la kubanda khona like e cementini zibebuhlungu. When I 
sit on a cold surface like cement, they get painful. Participant 61 
 
 Only 2% (n=1) reported pain caused by heat: 
 
Kodwa kuba isikhathi esincane, mangizifaka emanzini ashisayo 
zibabuhlungu  nakhona imizuzu emihlanu. But they are only painful if I 
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put them in hot water and even then it is just for 5 minutes. 
Participant 37 
 
 Additional phrases are presented in Appendix 3. 
 
3.4 SELECTION AND UNDERSTANDING OF ENGLISH NEUROPATHIC 
SYMPTOM DESCRIPTORS BY ISIZULU SPEAKERS 
The percentage of patients who chose each word to describe their symptoms 
from the list of English terms is indicated in figures 3.2a-j. “Cramping” (89%; 
figure 3.2i) was the most common English term chosen by participants to 
describe their neuropathic symptoms when prompted with the English 
neuropathic pain descriptors, followed by the terms “hot” (87%; figure 3.2a), 
“burning” (65%; figure 3.2a), “tight” (61%; figure 3.2i) and “itching” (59%; figure 
3.2d). 
  
The least chosen English words were “shooting” (63% said “no” when asked if 
the term described their symptoms; figure 3.2b) and “jumping” (50% said “no” 
when asked if the term described their symptoms; figure 3.2b). The least 
understood English terms by participants were “throbbing” (96% did not 
understand the term; figure 3.2h), “radiating” (83% did not understand the term; 
figure 3.2b), “tingling” (78% did not understand the term; figure 3.2d), “pricking” 
(72% did not understand the term; figure 3.2c), “aching” (70% did not understand 
the term; figure 3.2j) and “numb” (63% did not understand the term; figure 3.2j). 
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When prompted with the trigger for the pain, 32% (n=17) of participants reported 
that their symptoms were caused by heat, for example, a hot bath, and 46% 
(n=25) percent reported the symptoms of neuropathy caused by cold, for 
example, a cold day or a cold shower. Fifty four percent (n=29) said that the pain 
was caused by pressure to the feet and lower legs while standing, as well as skin 
contact when wearing socks, blankets or shoes.  
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71 
 
 
 
 
0%
20%
40%
60%
80%
100%
"Knife-like"/stabbing Pricking
3.2c) Punctate pressure don't know
no
yes
0%
20%
40%
60%
80%
100%
Tingling Itching
3.2d) Brightness
don't know
no
yes
0%
20%
40%
60%
80%
100%
Caused by heat Caused by cold Caused by 
pressure
3.2e) Evoked pain
don't know
no
yes
72 
 
 
 
 
0%
20%
40%
60%
80%
100%
Electric shock/electric Pins-and-needles
3.2f) Miscellaneous
don't know
no
yes
0%
20%
40%
60%
80%
100%
Sharp
3.2g) Incisive pressure
don't know
no
yes
0%
20%
40%
60%
80%
100%
Throbbing
3.2h) Temporal don't know
no
yes
73 
 
 
 
Figures 3.2a-j: Percentage of participants (n=54) who chose each English 
neuropathic pain descriptor to describe their neuropathic symptoms (red), those 
who did not choose each term (blue) and those who did not understand each 
term (green). The words from the list are grouped according to their position on 
the McGill Pain Questionnaire grouping of words. 
 
3.5 UNDERSTANDING OF ENGLISH TERMS 
We determined if the words chosen by participants to describe their neuropathic 
symptoms were truly understood by the participant or not. For example, for the 
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term “itching,” 32 out of the 54 participants chose the term to describe their pain. 
From the 32 participants, 26 had a true understanding of what “itching” meant. 
This was determined by looking at the isiZulu equivalents they provided for the 
term “itching” and then back-translating this equivalent into English. If it matched 
the English term, then participants were judged as having a true understanding of 
the English term. Table 3.2 shows the 21 neuropathic pain descriptors, the 
number of participants who chose the term to describe their symptoms and the 
number of these participants who had a true understanding of the English 
descriptor. 
 
Table 3.2: True and false understanding of the English-language neuropathic 
symptoms chosen by participants from the list of 21 English words to describe 
their neuropathic symptoms.   
 
English term 
Number of 
participants 
who chose 
term* 
Number of 
participants 
who had a 
true 
understanding 
of the term 
(%) 
Number of 
participants 
who had a 
false 
understanding 
of the term (%) 
 
isiZulu equivalents** 
1. Electric 
shock/electric 28 17 (61) 11 (39) 
kudonseka imisipha (feels like an 
electric shock) 
ugesi (electric shock) 
Engathi kuyoshoka (electric 
shock) 
2. “Knife-
like”/stabbing 19 11 (58) 8 (42) 
Iyahlaba (stabbing/pricking) 
Engihlaba (stabbing) 
3. Pins-and-
needles 23 17 (74) 6 (26) 
Ngihlatswa yinalithi (pins-and-
needles) 
4. Tight 33 19 (58) 14 (42) Ukuqina/ ziyaqina/ iyaqina (tight) 
 
5. Hot 47 46 (98) 1 (2) Ziyashisa/ ukushisa iyashisa/ kuyashisa (hot) 
6. Burning 35 32 (91) 3 (9) Ziyashisa/ ukushisa iyashisa/ kuyashisa (burning) 
7. Cold/ 
Freezing 30 25 (83) 5 (17) 
Ukubanda/ ziyabanda 
Ziyagodola 
Ziyabanda kakhulu (very cold) 
8. Tingling 9 3 (33) 6 (67) Ziyakitaza (tingling) 
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English term 
Number of 
participants 
who chose 
term* 
Number of 
participants 
who had a 
true 
understanding 
of the term 
(%) 
Number of 
participants 
who had a 
false 
understanding 
of the term (%) 
 
isiZulu equivalents** 
9. Pricking 5 3 (60) 2 (40) Ziyahlaba (pricking) Iyahlaba (pricking) 
10. Jumping 14 4 (29) 10 (71) ama cramps iwo ajampayo (it is 
cramps that are jumping) 
11. Shooting 3 1 (33) 2 (67) uzwa ngathi kukhona (It is pulling) 
12. Numb 16 12 (75) 4 (25) 
Ndikindiki (numb) 
Ziyalala (they are sleeping) 
Ziyasinda (they become heavy) 
 
13. Itching 32 26 (81) 6 (19) 
Ziyaluma (itching) 
Ukuluma (itching) 
Manginwaya (when I am 
scratching) 
14.Caused by 
heat 17 11 (65) 6 (35) 
mangigeza ngamanzi ashisayo 
ziba buhlungu khakulu (when I 
have a hot bath, they get painful) 
15. Caused by 
cold 25 14 (56) 11 (44) 
Uma kubanda (on a cold day) 
amanzi abandayo (cold water 
makes them more painful) 
16. Caused by 
pressure 29 22 (76) 7 (24) 
Uma ngibeka ingubo (when I put 
blankets on my feet) 
Uma ngifaka amasokisi noma 
izikathulo (when I put on socks or 
shoes) 
17. Aching 7 5 (71) 2 (29) Ubuhlungu (painful/aching) Ibabhuhlungu (painful/aching) 
18. Throbbing 1 1 (100) 0 (0) Like a heartbeat going “doof doof” 
19. Cramping 48 46 (95) 2 (5) 
Amakrempu/ Zibanamakrempu/ 
Amajaqamba/ namajaqamba/ 
Iyabambana (cramping/cramps) 
Ziyabambeka (they get stiff) 
20. Sharp 21 14 (67) 7 (33) Iyahlaba/ kuyahlaba/ bukhali (sharp) 
21. Radiating 4 1 (25) 3 (75) ubi kuyanyakaza (like there is 
something radiating/moving) 
*n=54 
**examples of the isiZulu equivalents for the English neuropathic symptom descriptors 
provided by participants if the English term described their symptoms.  
 
76 
 
The terms that majority of the participants had a true understanding of included 
“burning, hot, cramping, cold/freezing” and “itching”. The least understood terms 
chosen by participants to describe their symptoms were “radiating, jumping, 
shooting” and “tingling.”  
 
3.6 COMPARISON OF SPONTANEOUS TERMS VERSUS PROMPTED 
ENGLISH TERMS 
Table 3.3 shows the comparison of the spontaneous isiZulu terms used by 
participants to describe their symptoms to the English terms the same 
participants chose when prompted with the English symptom wordlist. The 
analysis was used to determine if participants used similar words when 
describing their neuropathic pain symptoms in both circumstances. A percentage 
concordance was calculated for each term. For example, 26 participants used the 
isiZulu term for “hot” to spontaneously describe their neuropathic pain symptoms 
and from the 26 participants, 24 (percentage concordance=92%) chose “hot” 
when prompted with the English term. Participants typically chose equivalent 
English words from the wordlist to those isiZulu words they spontaneously used 
to describe their symptoms. Participants chose many more additional words 
(median: 6 more words on average (interquartile range: 4-8 words)) to describe 
their symptoms when they were prompted with the terms. On average, there was 
an 80% level of agreement between the spontaneous and prompted terms. 
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Table 3.3: Comparison of the spontaneously used isiZulu terms to describe 
symptoms, to the prompted English terms chosen by participants when 
describing their symptoms. A percentage concordance was calculated for each 
term.  
 
Number of 
participants who 
spontaneously 
used the isiZulu 
term* 
Number of 
participants who 
chose the term when 
prompted with the 
English term 
% 
concordance 
Hot 26 24 92 
Cramping 19 18 95 
Itching 12 9 75 
Numbness 12 5 42 
Caused by 
pressure 11 7 64 
Cold/ 
Freezing 9 8 89 
Burning 4 2 50 
Pricking 3 0 0 
Knife-like/ 
Stabbing 3 2 67 
Caused by 
cold 2 2 100 
Pins-and-
needles 1 1 100 
Caused by 
heat 1 0 0 
Tight 1 1 100 
Electric 
shock 0 0 0 
Sharp 0 0 0 
Throbbing 0 0 0 
Aching 0 0 0 
Tingling 0 0 0 
Radiating 0 0 0 
Jumping 0 0 0 
Shooting 0 0 0 
    *n=54 
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3.7 IMPACT OF PAIN ON PARTICIPANTS’ DAILY ACTIVITIES 
The statements reflecting the impact of pain on the participants’ lifestyles are 
grouped by topic and the English translations are shown in bold lettering. 
Additional phrases are listed in Appendix 4. 
 
3.7.1 Sleep and pain at night 
For some of the participants, the pain seemed to be more prominent at night and 
in the morning.  Nineteen percent of participants (n=10) reported that sleep was 
affected by neuropathic pain:  
 
Ngalendlela zibuhlungu ngakhona, nginokuvhuka ebusuku ngi funa into 
yokuzenza ngcono. The way they are painful they make me wake up at 
night to look for something to make them better. Participant 50 
 
Nine percent of participants (n=5) reported feeling more pain at night: 
 
Ebusuku zibabuhlunge ngaphansi ngathi umuntu angangishaya, it seems 
as if all i-weight yami goes down, bese aya-paina. At night they get very 
painful, I wish someone could just hit me underneath; it seems as if 
all my weight has gone down to my feet and then they get painful. 
Participant 29 
 
3.7.2 Waking up in the morning 
Some participants (15%) also reported that the pain affected waking up in the 
morning or getting out of bed. 
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Uthola mhlawumbe uma ngisembhedeni kuba nzima ukwehla 
ngobuhlungu. You find that it becomes so difficult to get out of bed 
because of that pain.  Participant 7 
 
3.7.3 Daily activities affected by pain 
For some participants, walking and running (41%) was a painful experience: 
Ziba namajaqamba. They get cramps. Bese ngihluleka ukuhamba. 
Ngibambelele. Then I am unable to walk, I hold on to something. 
Participant 62 
 
For some participants (9%) the pain affected the type of footwear that could be 
worn.  
…and then even isihlangu asingeni, mina ndisebenzisa amaphaca nje 
kunetha kubanda. …and I can’t even wear proper shoes; I always 
have to wear sandals even when it’s cold. Participant 13 
 
3.7.4 The functional impact of neuropathic pain 
Pain associated with neuropathy also affected some participants functionally. The 
manner in which an individual copes with the pain and how they allow pain to 
affect their lives is dependent on the individual. For example, one participant 
reported a sense of hopelessness:  
 
Mina sendizincamile vele iindaba zenyawo, andisenalo nje ithemba. Even 
uDoctor ndandibuza ukuthi zizobanjani, wathi izinyawo endizohlala 
ndinazo, mandizidlele nje ama-ARVs no kudla nje oku-healthy, otherwise 
iinyawo zona azizukuya ndawo. So, kulapho nje ngavele ngalahl’ ithemba, 
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ngavele ngazamukela nje. I’ve given up on my feet ever getting better, 
I have no hope. I asked the Doctor once if my legs were going to get 
better, and he said no I should just focus on taking my ARVs and 
eating healthy, but my legs will always be sore. So, that is when I 
lost hope, and accepted the pain. Participant 13 
 
Another realised that the pain experience was something other people will not be 
able to empathise with:  
 
Kubuhlungu ngale ndlela ongayazi. It is painful in a way that you would 
never understand. Participant 4 
 
One participant said that she would not allow the pain to have a negative 
influence on her lifestyle: 
 
But yona akusiyo i pain yokuthi angeke ngikwazi ukuhamba, ngeke 
ngikwazi ukwenza lutho(“niks”). But it is not the pain that will prevent 
me from walking or doing anything. Participant 5 
 
The above statements illustrate that neuropathic pain affected the participant’s 
everyday living. Waking up in the morning, walking a short or long distance, 
running and sleep are a few of the daily activities affected. Activities that the rest 
of us find simple and effortless become a painful and uncomfortable experience 
for those with neuropathic pain.   
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4.1 Summary of findings 
Our objectives were to determine what words are used by isiZulu speakers with 
HIV-SN, to spontaneously describe their symptoms and to determine their 
understanding of common English neuropathic pain descriptors. The participants 
in the present study spontaneously described their symptoms, in isiZulu, as hot 
(“ziyashisa/ukushisa”), cramping (“amacramps/amajaqamba”), itching 
(“ziyaluma/kuyaluma”), numb (“ndikindiki”) or used phrases that indicated 
numbness in their feet and lower legs. When participants were prompted with 
English terms that are commonly found on existing assessment and diagnostic 
tools, participants chose the terms “cramping, hot, burning, itching” and “tight” to 
describe their symptoms of neuropathy. The present study shows that there are 
common terms used to describe the symptoms of neuropathy by European 
patients from previous studies and the South African participants in our study. 
Thus, neuropathic pain seems to display similar traits and characteristics in 
different racial and cultural groups. The few differences in descriptor choice could 
be due to the different causes of the neuropathies concerned. 
 
In addition to the objectives, we serendipitously found that HIV-SN had an impact 
on the lives of those with the neuropathy. The symptoms of neuropathy and the 
severity of these symptoms may have a negative impact on the participants’ 
everyday lifestyles, affecting their sleep patterns and daily activities and, in some 
participants the symptoms seemed to affect them in a functional manner. We can 
also conclude if using English-based questionnaires in the clinical and research 
settings in South Africa is appropriate or not as many individuals speak isiZulu as 
a home-language. We suggest the development of a neuropathic pain 
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questionnaire in a language that is appropriate and well understood by South 
African patients. The questionnaire should be developed from first principles as 
there are important terms that are essential in the diagnosis and assessment of 
neuropathic pain that were not understood or were misinterpreted by our 
participants.  
 
4.2 Discussion 
The terms “hot, burning and itching” emerged as the most frequent terms chosen 
by participants from the wordlist to describe the symptoms of neuropathic pain.  
In addition, the isiZulu words “ziyashisa/ukushisa” (hot/burning) and 
“ziyaluma/ukuluma” (itching) were amongst the most frequent terms 
spontaneously used by participants to describe their symptoms. Thus, the South 
African participants used terms that are commonly used to describe neuropathy 
symptoms by other populations and are commonly found on existing neuropathic 
pain questionnaires (Galer and Jensen, 1997; Bennett, 2001; Krause and 
Backonja, 2003; Bouhassira et al., 2004; Bouhassira et al., 2005; Portenoy, 
2006). Terms such as “hot and/or burning” are found on the NPS, LANSS, NPQ, 
NPSI, S-LANSS, DN4 and ID-Pain. The term “itching” occurs on the DN4 and the 
NPS. Despite cultural and linguistic differences, the symptomatology of 
neuropathic pain is apparently highly conserved.  
 
Throbbing, radiating, tingling, pricking, aching, and numb were the least 
understood and the least chosen terms to describe neuropathic pain. Although 
the term “throbbing” is usually associated with non-neuropathic pain (Rasmussen 
et al., 2004), our participants may have not chosen the term to describe their 
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symptoms simply because they did not understand what the term meant, with 
only 2% of participants understanding what “throbbing” meant.    
 
A single word, the term “cramping” is not frequently found on common 
neuropathic pain questionnaires (Galer and Jensen, 1997; Bennett, 2001; Krause 
and Backonja, 2003; Bouhassira et al., 2005; Portenoy, 2006). However, in the 
present study, “cramping” was used when participants spontaneously described 
their neuropathic pain symptoms (35%) and when they were prompted with the 
term (89%). This is consistent with the results obtained by Dubuisson and 
Melzack (1976) and Masson et al., (1989), who both found that cramping was 
one of the common terms used to describe the symptoms of neuropathic pain in 
patients with phantom limb pain and painful diabetic neuropathy, respectively. In 
addition to using the isiZulu term “amajaqamba,” to describe the cramp-like pain, 
some participants used words such as “ama-cramps” or “namacramps’’ to 
describe their pain. The latter terms are simple isiZulu derivatives from the 
English word “cramp.”  
 
The above information may prove to be vital when health care practitioners are 
assessing patients, who do not speak English as a first-language, with diabetes, 
HIV, cancer and patients with any other conditions who may be prone to 
developing a neuropathy. For example, if an HIV infected individual complains of 
“cramping” or “ama-cramps” in the lower legs, feet or toes, then the practitioner 
should not necessarily regard this as a muscle cramp, but should rather initiate 
further investigation or assessment for possible peripheral neuropathy. The early 
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detection of neuropathy will prevent further nerve damage by immediate provision 
of the correct treatment.  
 
It remains unclear whether isiZulu speakers and native English speakers assume 
the same meaning for the term “cramp.” However, participants frequently 
clenched their fists when describing a “cramping” pain, illustrating tightness or 
constriction, which is similar to the English meaning of a “cramp.” Furthermore, 
participants seemed to constantly regard the terms “cramping” and “tight” as 
describing the same symptom. For many participants, these terms meant the 
same thing and this was noted in the back-translation of the isiZulu terms they 
provided. In the wordlist created by Melzack and Torgerson (1971), “cramping” 
and “tight” were grouped in the constrictive pressure group, thus, if participants 
provided the isiZulu equivalent for “tight” when asked if they had a cramping pain, 
they were judged as having truly understood the terms and vice versa.  
 
Knife-like or stabbing was chosen by 19 participants and 29 participants did not 
know what these terms meant. “Iyahlaba, ziyahlaba, kuyahlaba” were the most 
common isiZulu equivalents given for the terms knife-like or stabbing. The same 
isiZulu equivalents were provided for the English terms “pricking” and “sharp”, 
suggesting that these three different symptoms are regarded as similar 
sensations to isiZulu speakers. “Stabbing” and “pricking” both belong to the 
punctate pressure group on the MPQ, whereas “sharp’ belongs to the “incisive 
pressure” group on the MPQ (Melzack, 1975). The subtlety of the words used to 
describe these different symptoms is thus lost in isiZulu and isiZulu speakers may 
possibly associate all four sensations with the same pain despite the terms being 
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associated with different pain intensities according to the MPQ. Alternatively, the 
context of how the word is used may indicate the magnitude of the stimulus.  
 
A lack of understanding the terms found on assessments and diagnostic tools 
may compromise the diagnosis of neuropathic pain or the treatment of 
neuropathic pain. Some terms from the list of English terms that were not well 
understood by participants’ if they chose the term to describe their symptoms 
included “tingling, jumping, shooting and radiating.”  For example, when asked if 
the term “tingling” described their symptoms, participants would provide isiZulu 
terms that, back-translated as “cramps,” “itching” or “tight.” When the term 
“jumping” was read to participants, they misinterpreted the term to imply physical 
jumping instead of a jumping pain sensation in the feet and lower legs.  Although 
the terms “tight” and “itching” were well understood universally, one participant 
misheard “tight” as “tired” while another associated “itching” with “eating.” This 
implies that using terms on English questionnaires for patients who are not first-
language English speakers is challenging as they may misinterpret many terms, 
even though they believe they understand the terms, or they may associate the 
terms with other English words as these words do not form part of their everyday 
vocabulary. This lack of understanding or misinterpretation may possibly lead to a 
misdiagnosis or under-diagnosis of neuropathic pain as patients could insist they 
have a symptom when in fact they are symptom-free, or they may deny having a 
symptom allowing the condition to progress.   
  
It may be beneficial to both health care providers and patients if the health care 
provider familiarised themselves with a few common terms that a patient may use 
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when describing his or her symptoms. For example, in the present study, 
“ziyashisa, ukushisa and iyashisa” were the isiZulu terms used spontaneously by 
participants to describe sensations of hotness and “ziyaluma, kuyaluma and 
ukuluma” were the isiZulu terms used to spontaneously describe itchiness. The 
common suffix in these terms is “-shisa” for hot and “-luma” for itchiness. As can 
be seen, there is no particular term that exists in the isiZulu language to describe 
a certain symptom and therefore, health care providers and researchers should 
take note of the suffix to determine what symptoms the patient or participant is 
presenting with when attempting to communicate with their patients.  
 
Similarly, when participants were prompted with the term “electric shock” to 
describe neuropathic pain, 28 participants chose electric shock to describe their 
neuropathic pain symptoms and 17 of these participants had a true 
understanding of the term. The common isiZulu terms and phrases used to 
describe the electric shock-like pain was “iyashoka” or “kuyashoka”. We see that 
participants used the suffix “-shoka” which is derived from the English term 
“shock”. 
  
The jargon term pins-and-needles, was also occasionally described as 
“ziyahlaba” while other descriptions included the isiZulu word “inalithi” or 
“izinalithi” (translated as “needles”). It is difficult to judge if patients truly 
understood the essence of a pins-and-needle-like sensation, even though they 
may have understood what the English terms “pins” and “needles” refer to. As 
Dubuisson and Melzack (1976) point out, an environmental reference may be 
associated with certain pain descriptors and they provide an example of a 
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burning pain resulting when a child burns on a hot stove. It remains questionable 
if participants in our study associated “pins-and-needles” with the environmental 
reference of an actual pricking pain of a needle as they provide the isiZulu 
equivalent for the word “needle” and further investigation is needed to determine 
this.    
 
Furthermore, as the description of pain is purely subjective in nature, researchers 
have to rely on the participant’s description of their own pain. This becomes 
difficult when participants themselves cannot provide answers relevant to the 
research. For example, when asked if pain was caused by pressure, a participant 
replied “I do not know what causes the pain” or when asked if the pain is caused 
by cold, a participant replied “when it is cold, I cannot sleep.” In the latter case it 
is unsure if the participant cannot sleep due to the pain caused by cold or due to 
the cold itself.   
 
Neuropathic pain also had an impact on the participants’ everyday lifestyles, as 
they spontaneously described to us. Although the various symptoms associated 
with neuropathic pain are a constant reminder of the condition, it may also have a 
negative influence on an individual’s everyday activities. For example, sleep is 
affected when an individual awakens during the night to either physically find 
some relief for the pain, or when an individual has to remove sheets or blankets 
as these evoke pain in the feet. Gray and Berger (2007) mention that sleep 
deprivation itself can cause worsened pain experience as the person is fatigued 
resulting in aggravated pain or the body’s response to pain may be impaired in 
HIV patients.    
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The impact of neuropathic pain on quality of life has been shown by Poliakov and 
Toth (2011). Findings from their study showed that patients with polyneuropathy 
and neuropathic pain were more likely to be unemployed compared to patients 
with polyneuropathy without neuropathic pain (Poliakov and Toth, 2011). Similarly 
to the present study, sleep was impaired by those patients with neuropathic pain 
and patients reported increased sleep disturbances and less hours of sleep. 
Furthermore, depression and anxiety symptoms seem to have s greater impact 
on quality of life in those individuals with neuropathic pain (Poliakov and Toth, 
2011).  
    
4.3 Conclusion and recommendations for further research studies 
In conclusion, the results from this study suggest that it is a better option to 
develop and validate a screening or assessment tool for neuropathy in South 
Africa from first principles, resulting in a new questionnaire. The mere forward 
and backward-translation of existing questionnaires should not be applied as the 
items on the questionnaire need to reach semantic, conceptual, experiential and 
idiomatic equivalence to guarantee that they are culturally acceptable for South 
African patients and participants. In the present study, participants provided 
different terms for the terms “hot, itching, pricking and cold/freezing” and so forth 
and an agreement on which terms to use should be made so that the 
questionnaire has semantic equivalence.  
 
In terms of experiential equivalence, the items used to illustrate what may evoke 
pain should also be considered. For example, as poverty is rife in South Africa, 
patients may not relate to socks, blankets or hot water and more easily 
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accessible items should be used to illustrate evoked pain. The term “pins-and-
needles” should be translated in such a way that it gets across the meaning of 
what the sensation actually feels like, hence reaching conceptual equivalence, 
instead of illustrating actual “pins” and “needles.” Furthermore, perhaps there is 
an idiomatic or colloquial expression that is easily understood by those who 
speak isiZulu to describe numbness or a knife-like pain and further language 
studies are proposed.  
 
In addition, it would be beneficial to create a new language-appropriate 
neuropathic pain questionnaire for the South African population as  the term 
“cramping,” used to describe the participants’ symptoms in our study, is not found 
on any other neuropathic pain questionnaires and will be lost if the existing tools 
are simply translated into isiZulu. Furthermore, terms commonly found on existing 
questionnaires, such as “tingling, electric-shock like, jumping, and sharp” were 
not chosen by participants to describe their symptoms as they did not experience 
the symptom or they did not understand the term and including these terms in an 
isiZulu questionnaire will thus be to no avail. Simply translating questionnaires 
into isiZulu could be problematic and may not adequately measure pain. This 
knowledge may also apply to other verbal pain scales that require translation into 
an African language.   
 
Terms such as “hot,” “burning” and “itching,” that were used to describe 
neuropathy symptoms in South Africans who speak isiZulu as a home-language, 
are similar to the terms used by English speakers and European populations. The 
similar terms suggest that the symptoms of neuropathic pain do not discriminate 
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between individuals from various cultural and racial groups. From the present 
study we can conclude whether or not English neuropathic pain questionnaires 
that are used globally (in the United Kingdom, European countries and the United 
States of America), are appropriate for South African patients who speak isiZulu 
as a home-language. The results from our study show that certain key terms 
such as “numb,” “tingling,” and “pricking”, used in the assessment and diagnosis 
of neuropathic pain are not well understood by South Africans who speak isiZulu 
as a home-language, therefore, we propose the development of a neuropathic 
pain questionnaire that is language-appropriate for South African patients. A 
language-appropriate questionnaire will improve the diagnosis of neuropathy in 
South African patients, will result in more accurate data for epidemiological and 
clinical studies, and will add validation to cultural studies. 
 
4.4. Limitations to the study 
The most important limitation to the study is the fact that the primary investigator 
does not speak isiZulu as a first or second-language. The language barrier 
between primary investigator and participant made it rather difficult to 
communicate, and the study purpose, as well as what was expected of 
participants, may not have been fully understood by participants. However, the 
advantage of the primary investigator’s lack of isiZulu knowledge may have 
prevented biased data and the results are thus objective in nature. There was a 
translator present at all times during the data collection period, who facilitated 
communication with the investigator. 
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Participants could have felt intimidated when the terms that were read to them 
were not fully understood and instead of responding with “I do not understand the 
term,” participants responded with “no,” despite being told that it was acceptable 
if they did not understand the term. It was thus difficult to judge if participants truly 
understood the term or not, and we based the results on the manner in which 
participants responded, for example, how hesitant or puzzled a participant was 
when responding to the question. The environment in which the interview was 
carried out and recorded was not the most suitable as it was prone to noise and 
there may have been interruptions when individuals, not part of the study design, 
would occasionally walk into the room where the interview was taking place. The 
above may have distracted participants and the recordings were occasionally 
unclear to the transcribing and translating company due to the noise. We suggest 
conducting interview research in rooms that are completely silent and prone to as 
little disturbance as possible. These limitations should be considered for future 
language studies based on interview nature, as improving the overall study 
design will result in improved and more accurate data for qualitative research. 
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APPENDIX 1: McGill Pain Questionnaire 
McGILL PAIN QUESTIONNAIRE 
 
1   2   3   4 
1. Flickering  1. Jumping  1. Pricking  1. Sharp 
2. Quivering  2. Flashing  2. Boring  2. Cutting 
3. Pulsing  3. Shooting  3. Drilling  3. Lacerating 
4. Throbbing     4. Stabbing 
5. Beating     5. Lancinating 
6. Pounding 
 
 
 5   6   7   8 
1. Pinching  1. Tugging  1. Hot   1. Tingling 
2. Pressing  2. Pulling  2. Burning  2. Itching 
3. Gnawing  3. Wrenching  3. Scalding  3. Smarting 
4. Cramping     4. Searing  4. Stinging 
5. Crushing 
 
 
 9   10   11   12 
1. Dull   1. Tender  1. Tiring  1. Sickening 
2. Sore  2. Taut   2. Exhausting  2. Suffocating 
3. Hurting  3. Rasping 
4. Aching  4. Splitting 
5. Heavy 
 
 
 13   14   15   16 
1. Fearful  1. Punishing  1. Wretched  1. Annoying 
2. Frightful  2. Gruelling  2. Blinding  2. 
Troublesome 
3. Terrifying  3. Cruel     3. Miserable 
4. Vicious     4. Intense 
5. Killing     5. Unbearable 
 
 
 17   18   19   20 
1. Spreading  1. Tight  1. Cool   1. Nagging 
2. Radiating  2. Numb  2. Cold   2. Nauseating 
3. Penetrating  3. Drawing  3. Freezing  3. Agonising 
4. Piercing  4. Squeezing     4. Dreadful 
5. Torturing 
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Present Pain Intensity (PPI) 
 
 
People agree that the following 5 words represent pain in increasing intensity. 
They are: 
 
  1      2   3      4            5                
Mild           Discomforting             Distressing           Horrible            Excruciating 
 
Which would best describes your present pain?   ___________ 
 
VAS PAIN RATING 
 
In your experience, how would you rate he pain you are currently feeling: 
 
 No pain    _______________________________________________ The worst   
               pain I have  
         ever felt 
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APPENDIX 2: Neurological Screening Tool 
Neurological Screening Tool 
1. Symptoms 
Do you experience any pain or abnormal sensations in your feet or 
lower legs?                               YES             NO 
 
 
Please describe the intensity of you pain: 
 
                     Mild            Moderate        Severe 
 
 
 
 
2. Signs 
 
Instructions for evaluating perception of vibration 
 
Strike the end of a 128 Hz tuning fork hard enough that the sides 
touch. Place the vibrating tuning fork on a bony prominence on the 
subject’s wrist to be sure that they can recognize the vibration or 
“buzzing” quality of the tuning fork. Again, strike the ends of the tuning 
fork hard enough so that the sides touch. Immediately place the 
vibrating tuning fork gently but firmly on the top of the distal 
interphalangeal (DIP) joint of one great toe and begin counting the 
seconds. Instruct the subject to tell you when the “buzzing” stops. 
Repeat for the other great toe.  
 
2.1 Vibration sense: 
 
a. Great toe DIP joint perception of end of vibration in seconds    R         L             
 
      b. Vibration perception score:     R           L 
 
                    Vibration perception     
               0=felt ≥ 10 seconds 
               1=felt < 10 seconds    
     
Page 1 of 2 
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INSTRUCTIONS FOR EVALUATING DEEP TENDON REFLEXES 
 
With the subject seated, the examiner uses one hand to press 
upward on the ball of the foot, dorsiflexing the subject’s ankle to 90 
degrees. Using a reflex hammer, the examiner then strikes the 
Achilles tendon. The tendon reflex is felt by the examiner’s hand as 
a plantar flexion of the foot, appearing after a slight delay from the 
time the Achilles tendon was struck. Use reinforcement, if 
necessary, by having the subject clench fist. 
 
 
 
2.2Ankle Reflexes:   R              L 
 
                          
Ankle Reflexes 
                           0= absent 
                           1=present   
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 2 of 2 
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APPENDIX 3: Spontaneous verbal pain descriptions of neuropathic pain 
symptoms 
Additional examples of the spontaneous verbal descriptions used by participants 
to describe their symptoms are shown below. The phrases are in isiZulu, just as 
the participant had said, and the English translations are shown below it. The 
underlined terms are the terms found in Table 3.1 of Chapter 3: Results. 
Uma ngilele ngizwa ngibanjwa ama-cramps.   
I get a lot of cramps. Participant 18 
 
So, sometimes ziba namajaqamba.   
They also get cramps sometimes. Participant 61 
 
Ziyaluma.   They are itchy.  Participant 35 
 
Izinyawo nziyahlaba umangime isikhathi eside. If I have been standing, they 
start stabbing. Participant 35 
 
 …kodwa ngizwa kuthi noma ngihamba ngizwa ubuhlungu.  
 …and (they) got painful when I walked.   Participant 50 
 
…bese ziyabanda sometimes…    
 …and sometimes they feel cold… Participant 12 
 
Uthole ukuthi sometimes ngibacela ukuthi bangirabhe, ababuhlungu kakhulu 
mabangibamba, inyawo libabuhlungu kakhulu.  
I sometimes ask them to massage my feet, but they become more painful when 
they touch them. Participant 30 
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Nokuthi sometimes zinokuba-numb.   
Sometimes they feel numb. Participant 23 
 
Uma sengizwa lezizinhlungu, iminwe yezinyawo iba ndikindiki, angiyizwa.  
My toes are numb, I cannot feel them. Participant 58 
 
Kuyahlaba nje.  It is pricking. Participant 8 
 
...and then sometimes kuba sengathi kuyahlaba ngaphansi kwenyawo.  
 ...and then sometimes I get pins-and-needles under my feet. Participant 29 
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APPENDIX 4: Impact of pain on everyday lifestyles 
Listed below are the isiZulu phrases and English translations of the spontaneous 
verbal responses given by participants which show the impact pain has had on 
their lives. These additional phrases are an appendix to section 3.7 in Chapter 3: 
Results. 
 
3.7.1 Sleep and pain at night 
 Ebusuku angifaki ingubo noma kubanda kanjani, ziyashisa. I don’t wear 
anything at night, no matter how cold they are hot.  Participant 4 
 
And then ke nama-cramp mara hayi everyday. Ngize ngithathe i-ice ngiyibeke 
lapho kube ngathi kuya-stopa. Ngoba mangilele impela ngiyavuka ngilishaye 
phansi ukuthi yiyo nje into engingathi ingiphethe kakhulu. I also have cramps 
sometimes but not all the time and I put ice on my leg to make it better. I get 
them even when I’m sleeping and then I have to get out of bed and jump up 
and down. That is my major problem. Participant 16 
 
Ja mangilele ziba buhlungu kakhulu. Yes they are very painful when I am 
sleeping.  Participant61 
 
3.7.2 Waking up in the morning 
Uma ngivuka ekuseni angikhoni ukunyathela. I can’t even stand when I wake 
up in the morning. Participant 12 
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Futhi uma ngivuka ekuseni, ngathi langaphansi kunento efana neqhwa. And 
when I wake up in the morning it feels like my feet have ice underneath. 
Participant 47 
 
3.7.3 Daily activities affected by pain 
And then mangihambe uthola kuthi isicathulo siyaphuma angizwa ukuthi 
isicathulo siphumile. Sometimes my shoe would come out whilst I am 
walking but I would not feel that it is gone. Participant 59 
 
And kakhulu “ziyangiaffecta” uma ngigijima. And also they affect me especially 
when I am running. Participant 5 
 
Kusho ukuthi le pain isuka la emadolweni bese yehla ngemilenze. Mayifika 
laphansi kwezinyawo, yenze engathi nginyathela amaqhwa. This pain starts 
from the knees and it goes down my legs and when it get to my feet it 
makes me walk like I am walking on ice. Participant 7 
 
Uma ngihamba kunalento engidonsayo ngingakhoni ukushesha bese ngizwa 
engathi ngiyakhathala. When I am walking it feels like there is something 
pulling me and I am not able walk fast and I feel like I am getting tired. 
Participant 3 
 
 
113 
 
ADDITIONAL: Interesting and unique phrases to describe neuropathic pain 
Participants also provided interesting and unique phrases indicating how they, as 
individuals, perceive pain and sensations associated with neuropathic pain: 
 
Kwesinye isikhathi uthola ukuthi izinyawo ziyashisa uma uthi uzikhiphela phandle 
kwengubo nakhona zibande. Then awazi ukuthi wenzenjani manje. Ngihlale 
ngizihlikihla nakhona kushise. Sometimes ngithatha ama ice cubes ngithi 
ukuzipholisa. Sometimes you find that my feet are hot but when I take them 
out of the blanket they get cold, and you just don’t know what to do. I am 
always rubbing them but they also get hot from rubbing and I have to use 
the ice cubes to cool them off. Participant 58 
 
Kutholakale ukuthi lokuluma kungaphakathi. Akukho ngaphakathi esikhumbeni. 
You find that the itch is inside the skin, not on the surface of the skin. 
Participant 10 
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